Visual field defects

H7_VISFIELDDEF

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 H53.4
  • Hospital discharge: ICD-9 3684
  • Cause of death: ICD-10 H53.4
  • Cause of death: ICD-9 3684

2 out of 7 registries used, show all original rules.

3326

4. Check minimum number of events

None

3326

5. Include endpoints

None

3326

6. Filter based on genotype QC (FinnGen only)

3326

Control definitions (FinnGen only)

Control exclude
H7_VISUALDISTBLIND

Extra metadata

Level in the ICD hierarchy
4
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
H53
Name in latin
Defectus campi visualis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 23456 11336 11957
Only index persons 21057 10440 10617
Unadjusted period prevalence (%)
Whole population 0.33 0.32 0.33
Only index persons 0.39 0.38 0.41
Median age at first event (years)
Whole population 61.46 60.49 62.29
Only index persons 60.42 59.50 61.34

-FinnGen-

Key figures

All Female Male
Number of individuals 3326 1704 1622
Unadjusted period prevalence (%) 0.65 0.58 0.72
Median age at first event (years) 61.09 57.24 65.13

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
2984
Matched controls
29840
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
9.3
323.0
751
1043
XCK00
NOMESCO Finland
Perimetry
16.0
323.0
977
880
H53.4
ICD-10 Finland
Visual field defects
4503599627370496.0
323.0
2960
17
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
7.4
323.0
895
1628
Z01.0
ICD-10 Finland
Examination of eyes and vision
5.4
281.1
1022
2631
H53.1
ICD-10 Finland
Subjective visual disturbances
23.0
276.0
408
204
AA1AD
NOMESCO Finland
CT of head and brain
4.4
266.0
1286
4404
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
6.2
175.6
517
970
I63.4
ICD-10 Finland
Cerebral infarction due to embolism of cerebral arteries
8.8
140.5
317
396
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
9.2
134.1
294
349
XCW99
NOMESCO Finland
Other investigative procedure of eye
4.0
129.9
595
1749
I63.3
ICD-10 Finland
Cerebral infarction due to thrombosis of cerebral arteries
6.9
128.5
343
552
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
29.5
124.6
170
61
H53.2
ICD-10 Finland
Diplopia
49.4
112.7
137
29
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
5.6
109.7
347
690
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
4.1
108.5
473
1312
CS494
NOMESCO Finland
Other visual field testing
10.0
104.2
217
233
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
4.3
99.7
409
1067
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
17.1
97.7
158
97
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
8.3
92.2
214
276
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
17.8
91.6
146
86
XA800
NOMESCO Finland
Neuropsychological investigation
6.0
90.1
263
470
B01AC30
ATC
platelet aggregation inhibitors excl. heparin - combinations
4.2
88.8
371
979
AAE10
NOMESCO Finland
Transsphenoidal total or partial excision of intracranial lesion
37.0
88.6
114
32
K90
ICPC
Stroke/cerebrovascular accident
7.1
82.5
211
315
H53.9
ICD-10 Finland
Visual disturbance, unspecified
10.6
79.8
160
159
B01AC04
ATC
clopidogrel; oral
2.7
79.7
668
2923
H47.2
ICD-10 Finland
Optic atrophy
37.9
77.4
99
27
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
9.3
77.4
166
187
N03AX14
ATC
levetiracetam; systemic
7.1
76.9
197
294
R51.80
ICD-10 Finland
Headache
2.9
76.8
540
2117
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
11.4
75.8
146
134
H02AB09
ATC
hydrocortisone; systemic
7.9
75.0
178
237
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
7.8
73.9
177
239
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
8.2
72.6
169
218
E23.00
ICD-10 Finland
Panhypopituitarism
31.9
72.2
96
31
PA6DE
NOMESCO Finland
Neck artery ultrasound examination with Doppler method
4.5
70.3
267
638
G45.9
ICD-10 Finland
Transient cerebral ischaemic attack, unspecified
3.4
68.0
363
1167
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
4.0
67.9
297
810
H54.2
ICD-10 Finland
Moderate visual impairment, binocular
82.0
64.2
72
9
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
14.7
63.3
108
76
N03AF02
ATC
oxcarbazepine; oral
5.4
62.2
195
378
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
14.4
62.1
107
77
B01AA03
ATC
warfarin; systemic
2.2
61.6
788
4198
H46
ICD-10 Finland
Optic neuritis
20.0
61.2
93
48
101
Kela drug reimbursment
Anterior pituitary hypofunction
20.6
61.2
92
46
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.9
60.8
1402
9445
PA6BD
NOMESCO Finland
Extensive CT of neck arteries
4.6
60.5
222
511
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
7.8
59.9
143
192
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.4
59.2
603
2874
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
7.0
58.2
149
222
G40.9
ICD-10 Finland
Epilepsy, unspecified
5.0
57.1
194
411
XCD10
NOMESCO Finland
Electrophysiological examination of eye
5.9
57.0
167
298
XCK10
NOMESCO Finland
Photography of fundus of eye
2.7
55.3
416
1673
I69.1
ICD-10 Finland
Sequelae of intracerebral haemorrhage
8.8
50.4
111
131
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
50.1
567
2818
R56.8
ICD-10 Finland
Other and unspecified convulsions
3.7
46.7
219
629
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
8.0
46.5
108
139
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
45.6
302
1115
N03AG01
ATC
valproic acid; systemic, rectal
3.3
44.4
238
759
R4120
NOMESCO Finland
Occupational therapy
3.1
43.8
259
885
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
2.1
43.7
547
2829
H47.0
ICD-10 Finland
Disorders of optic nerve, not elsewhere classified
17.5
42.4
67
39
Z3229
NOMESCO Finland
Other healthcare associate professional
2.6
42.0
333
1370
G43.1
ICD-10 Finland
Migraine with aura [classical migraine]
3.5
41.7
209
633
N18
ICPC
Paralysis/weakness
6.2
40.9
114
191
ZXA10
NOMESCO Finland
Bilateral
2.0
40.7
610
3388
I67.1
ICD-10 Finland
Cerebral aneurysm, nonruptured
6.4
40.5
110
178
C10AA05
ATC
atorvastatin; oral
1.7
40.0
1167
8112
ZXD05
NOMESCO Finland
Urgent procedure
1.8
39.5
950
6223
FM1BE
NOMESCO Finland
Cardiac ultrasound examination through oesophagus
2.9
39.0
257
943
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
2.8
38.9
262
976
AAC00
NOMESCO Finland
Ligature of intracranial aneurysm
9.1
38.5
82
92
Z2445
NOMESCO Finland
Psychologist
4.0
38.0
161
424
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
5.3
37.6
119
233
102
Kela drug reimbursment
Diabetes insipidus
33.2
37.6
49
15
R4150
NOMESCO Finland
Neuropsychological rehabilitation
12.9
37.5
67
53
PA7BD
NOMESCO Finland
CT angiography of neck and brain
6.7
36.7
96
148
I63.0
ICD-10 Finland
Cerebral infarction due to thrombosis of precerebral arteries
6.4
36.6
99
160
PA2BD
NOMESCO Finland
Extensive CT angiography of brain
5.8
36.0
105
187
N02BE01
ATC
paracetamol; systemic, rectal
1.8
35.9
2479
21715
R42
ICD-10 Finland
Dizziness and giddiness
1.9
35.8
680
4094
K91
ICPC
Cerebrovascular disease
7.1
35.6
89
129
TAB00
NOMESCO Finland
Lumbar puncture
3.6
35.2
168
489
Z96.1
ICD-10 Finland
Presence of intraocular lens
2.1
34.9
426
2162
I63.8
ICD-10 Finland
Other cerebral infarction
9.8
34.8
71
74
B01AC07
ATC
dipyridamole; systemic
3.0
34.2
213
754
PA2BC
NOMESCO Finland
Cerebral extensive angiography with X-ray
9.2
34.0
72
80
I69.0
ICD-10 Finland
Sequelae of subarachnoid haemorrhage
8.7
33.8
74
87
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
7.8
32.9
77
101
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.6
32.7
1147
8263
D44.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pituitary gland
22.7
32.6
47
21
XF400
NOMESCO Finland
ECG with 12 standard connections
1.9
32.5
524
2967
AA5BD
NOMESCO Finland
CT of cerebral ischaemia
5.2
32.3
103
204
I63.1
ICD-10 Finland
Cerebral infarction due to embolism of precerebral arteries
6.9
31.9
81
120
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
9.7
31.8
65
68
C10AA01
ATC
simvastatin; oral
1.6
31.8
1306
9778
SPAT1226
SPAT
Implementation of occupational therapy rehabilitation plan
4.1
31.2
125
313
I10
ICD-10 Finland
Essential (primary) hypertension
1.6
31.1
1689
13519
C03CA01
ATC
furosemide; systemic
1.7
31.0
903
6161
183
Kela drug reimbursment
Lamotrigin and topiramate
8.2
30.5
69
86
N03AX18
ATC
lacosamide; systemic
10.5
30.2
59
57
N03AB02
ATC
phenytoin; systemic
6.4
30.0
80
127
D35.30
ICD-10 Finland
Craniopharyngoma
68.6
29.9
34
5
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
8.7
29.9
65
76
H53.0
ICD-10 Finland
Amblyopia ex anopsia
37.4
29.3
37
10
H47.1
ICD-10 Finland
Papilloedema, unspecified
15.2
29.1
48
32
H40.11
ICD-10 Finland
Low pressure glaucoma
4.6
28.9
102
226
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.7
28.8
731
4774
I61.9
ICD-10 Finland
Intracerebral haemorrhage, unspecified
5.3
28.7
89
171
C07AB07
ATC
bisoprolol; oral
1.5
28.6
1392
10762
A28
ICPC
Limited function/disability NOS
1.9
28.4
476
2717
I61.0
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, subcortical
5.1
28.4
92
186
I60.9
ICD-10 Finland
Subarachnoid haemorrhage, unspecified
6.0
28.1
79
135
I63.5
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of cerebral arteries
6.0
28.1
79
135
WX408
NOMESCO Finland
General anesthesy, balanced
1.7
28.0
769
5130
AA5PD
NOMESCO Finland
CT examination of brain pefusion
10.4
27.9
55
54
CA1CG
NOMESCO Finland
Eye and orbita extensive MRI examination with high intensity magnet
11.0
27.8
53
49
Z3231
NOMESCO Finland
Registered nurse
1.6
27.7
815
5544
R53
ICD-10 Finland
Malaise and fatigue
1.8
27.5
599
3729
N03AF01
ATC
carbamazepine; oral, rectal
2.7
27.5
196
755
PA7CD
NOMESCO Finland
CT angiography of neck and brain, extensive
6.8
27.5
70
105
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
10.4
27.4
54
53
I61.1
ICD-10 Finland
Intracerebral haemorrhage in hemisphere, cortical
8.8
27.4
59
68
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
26.8
631
4018
I63
ICD-10 Finland
Cerebral infarction
9.5
26.2
54
58
A02BC02
ATC
pantoprazole; systemic
1.5
25.8
1805
14997
L01AX03
ATC
temozolomide; systemic
9.1
25.7
54
60
H34.2
ICD-10 Finland
Other retinal artery occlusions
9.8
25.7
52
54
AA1BD
NOMESCO Finland
Extensive CT of head and brain
3.9
25.6
109
289
R06.0
ICD-10 Finland
Dyspnoea
1.7
25.6
709
4722
CA1CM
NOMESCO Finland
Eye and orbita extensive MRI examination with 3 Tesla magnet
44.7
25.5
31
7
F05
ICPC
Visual disturbance other
3.9
25.4
106
276
ZXE10
NOMESCO Finland
More than one and less than three hours
1.6
25.3
1027
7538
G35
ICD-10 Finland
Multiple sclerosis
6.2
25.3
69
114
PA2CC
NOMESCO Finland
Cerebral very extensive angiography with X-ray
8.6
25.3
55
65
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
6.9
24.6
62
92
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
4.2
24.2
93
225
Z2446
NOMESCO Finland
Social worker
2.4
23.9
211
914
ZXC95
NOMESCO Finland
Use of surgical navigator
5.8
23.8
68
119
SPAT1224
SPAT
Implementation of speech therapy rehabilitation plan
5.1
23.8
76
152
ZXE20
NOMESCO Finland
More than three and less than five hours
1.8
23.8
429
2502
H02AB06
ATC
prednisolone; systemic
1.5
23.5
1293
10113
L28
ICPC
Limited function/disability (L)
1.8
23.5
460
2756
N19
ICPC
Speech disorder
6.1
23.4
64
106
N06AX11
ATC
mirtazapine; oral
1.6
23.3
868
6214
I50.9
ICD-10 Finland
Heart failure, unspecified
1.8
23.2
428
2512
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
13.5
23.2
40
30
H01BA02
ATC
desmopressin; nasal, systemic, sublingual
4.7
23.1
79
170
WX892
NOMESCO Finland
Monitored bed care
2.2
23.1
256
1233
R47.0
ICD-10 Finland
Dysphasia and aphasia
6.7
23.0
59
90
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.6
22.9
823
5837
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
7.7
22.8
53
70
AAF00
NOMESCO Finland
Ventriculostomy
9.3
22.7
47
51
H54.4
ICD-10 Finland
Blindness, monocular
84.1
22.7
25
*
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.5
22.5
872
6288
H40.0
ICD-10 Finland
Glaucoma suspect
2.2
22.5
240
1136
N29
ICPC
Neurological sympt/complt other
4.7
22.5
78
171
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.7
22.4
522
3292
SPAT1229
SPAT
Assessment of need for aid
2.1
22.3
255
1247
I60.1
ICD-10 Finland
Subarachnoid haemorrhage from middle cerebral artery
10.1
22.3
44
44
N05BA09
ATC
clobazam; oral
9.0
22.3
47
53
3684A
ICD-9 Finland
Visual disturbances, Visual field defects[HOMONYYMIT NÄKÖKENTTÄPUUTOKSET]
+∞
21.9
21
*
G44.2
ICD-10 Finland
Tension-type headache
1.9
21.8
342
1898
TPH04
NOMESCO Finland
Cathetrisation of vein
1.6
21.7
595
3929
C09AA05
ATC
ramipril; oral
1.6
21.6
722
5017
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
4.1
21.5
84
207
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.8
21.3
435
2636
C07AB02
ATC
metoprolol; systemic
1.6
21.1
632
4265
SPAT1216
SPAT
Assessment of functional ability
1.7
21.1
452
2776
G81.9
ICD-10 Finland
Hemiplegia, unspecified
5.9
21.0
59
102
AA4CM
NOMESCO Finland
Extensive MRI examination of sella turcica with 3 Tesla magnet
28.2
20.9
28
10
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.9
20.9
328
1819
R50.9
ICD-10 Finland
Fever, unspecified
1.8
20.4
389
2302
N03AX09
ATC
lamotrigine; oral
2.8
20.4
137
508
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
11.3
20.4
38
34
114
Kela drug reimbursment
Glaucoma
2.0
20.4
279
1468
H03AA01
ATC
levothyroxine sodium; systemic
1.6
20.3
614
4149
N03AX12
ATC
gabapentin; oral
1.7
20.1
422
2576
G45.3
ICD-10 Finland
Amaurosis fugax
4.1
19.8
78
194
H54.7
ICD-10 Finland
Unspecified visual loss
9.6
19.8
40
42
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
19.7
680
4746
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
2.3
19.5
183
817
G45.1
ICD-10 Finland
Carotid artery syndrome (hemispheric)
2.7
19.5
135
510
109
Kela drug reimbursment
Multiple sclerosis
7.4
19.4
46
63
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
4.9
19.3
63
130
H54.3
ICD-10 Finland
Mild or no visual impairment, binocular
26.2
19.1
26
10
H01AC01
ATC
somatropin; parenteral
22.7
19.0
27
12
T90.5
ICD-10 Finland
Sequelae of intracranial injury
5.9
19.0
53
91
G43.9
ICD-10 Finland
Migraine, unspecified
2.6
19.0
144
575
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
19.0
572
3857
Z3226
NOMESCO Finland
Physiotherapist
1.6
19.0
514
3369
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
18.9
865
6428
H04.10
ICD-10 Finland
Dry eye syndrome
2.0
18.8
261
1378
S01ED51
ATC
timolol, combinations; ophthalmic
2.1
18.8
232
1170
AA4BG
NOMESCO Finland
MRI examination of sella turcica with high intensity magnet
15.9
18.8
30
19
G45.0
ICD-10 Finland
Vertebro-basilar artery syndrome
3.2
18.7
102
331
303
Kela drug reimbursment
Dimethyl fumarate, interferon beta, glatiramer acetate and teriflunomid (Multiple sclerosis)
8.0
18.7
42
53
N03AX11
ATC
topiramate; oral
3.6
18.6
84
236
AAB30
NOMESCO Finland
Evacuation of spontaneous intracranial haematoma
23.8
18.6
26
11
G40.10
ICD-10 Finland
Simple partial seizures
7.6
18.6
43
57
N06AB04
ATC
citalopram; systemic
1.6
18.6
565
3817
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.1
18.6
226
1134
A02BC01
ATC
omeprazole; systemic
1.5
18.5
754
5456
R20.2
ICD-10 Finland
Paraesthesia of skin
2.3
18.5
182
832
H25.1
ICD-10 Finland
Senile nuclear cataract
1.5
18.5
725
5202
CJB10
NOMESCO Finland
Laser discission of secondary cataract
2.0
18.5
243
1260
H26.4
ICD-10 Finland
After-cataract
1.9
18.4
268
1443
ZXE00
NOMESCO Finland
One hour or less
1.4
18.4
1062
8256
WX872
NOMESCO Finland
Intensive care
2.4
18.3
165
723
SPAT1254
SPAT
Administration of medicine
1.7
18.0
417
2618
N03AG04
ATC
vigabatrin; oral
33.1
17.9
23
7
R5210
NOMESCO Finland
Assessment of the improvements needed in the living environment
13.0
17.9
31
24
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.5
17.8
768
5623
I25.9
ICD-10 Finland
Chronic ischaemic heart disease, unspecified
1.8
17.8
316
1826
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.5
17.6
928
7069
XF404
NOMESCO Finland
Ambulatory ECG
1.9
17.6
277
1535
H33.0
ICD-10 Finland
Retinal detachment with retinal break
3.2
17.6
93
296
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
36.9
17.6
22
6
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
6.5
17.5
45
70
Q28.2
ICD-10 Finland
Arteriovenous malformation of cerebral vessels
15.7
17.5
28
18
C08CA01
ATC
amlodipine; oral
1.4
17.4
978
7544
SPAT1231
SPAT
Assessment of adjustments needed in living environment
3.6
17.3
78
220
157
Kela drug reimbursment
Dimethyl fumarate, glatiramer acetate, interferon beta and teriflunomid (Multiple sclerosis)
8.2
17.2
38
47
315
Kela drug reimbursment
Clopidogrel
4.7
17.2
58
125
G91.0
ICD-10 Finland
Communicating hydrocephalus
9.8
17.1
34
35
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.7
17.0
378
2341
SPAT1217
SPAT
Assessment of need for services (elderly/care support)
2.0
17.0
223
1154
181
Kela drug reimbursment
Retigabine and vigabatrin
50.3
17.0
20
*
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.5
16.9
760
5597
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.0
16.8
41
59
M03BX01
ATC
baclofen; systemic
4.2
16.8
64
156
I63.2
ICD-10 Finland
Cerebral infarction due to unspecified occlusion or stenosis of precerebral arteries
5.6
16.6
48
87
XCH00
NOMESCO Finland
Eye pressure measurement
2.5
16.4
128
521
WX140
NOMESCO Finland
Parabulbar anesthesy
2.5
16.2
131
544
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
1.9
16.1
249
1371
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
9.5
15.9
32
34
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
1.8
15.7
275
1580
E89.30
ICD-10 Finland
Postprocedural hypopituitarism
85.5
15.6
17
*
H47.3
ICD-10 Finland
Other disorders of optic disc
11.8
15.5
28
24
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
1.6
15.5
420
2741
H52.1
ICD-10 Finland
Myopia
3.1
15.4
85
280
H35.39
ICD-10 Finland
Degeneration of macula and posterior pole
2.7
15.4
103
383
TPX22
NOMESCO Finland
Intravenous arterial thrombolysis
5.8
15.4
43
75
N02AX02
ATC
tramadol; systemic, rectal
1.4
15.2
1122
9042
E23.2
ICD-10 Finland
Diabetes insipidus
14.0
15.0
25
18
SPAT1215
SPAT
Assessment of need for medical rehabilitation
2.4
15.0
126
535
E78.5
ICD-10 Finland
Hyperlipidaemia, unspecified
1.8
15.0
276
1611
I67.9
ICD-10 Finland
Cerebrovascular disease, unspecified
5.7
14.9
42
74
B01AB05
ATC
enoxaparin; parenteral
1.4
14.9
797
6054
TPH07
NOMESCO Finland
Cathetrisation of artery
1.7
14.9
294
1756
YX8VG
NOMESCO Finland
Stereotactic MRI exmaination with high intensity magnet for dose design of radiotherapy
12.5
14.8
26
21
H54.1
ICD-10 Finland
Severe visual impairment, binocular
56.9
14.8
17
*
S01EE01
ATC
latanoprost; ophthalmic
2.0
14.8
185
939
N01
ICPC
Headache
1.9
14.8
227
1246
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
2.5
14.7
120
498
207
Kela drug reimbursment
Chronic arrhythmias
1.6
14.7
427
2836
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
14.7
638
4647
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.6
14.5
413
2730
R07.4
ICD-10 Finland
Chest pain, unspecified
1.5
14.5
694
5153
N03AX16
ATC
pregabalin; oral
1.5
14.4
599
4323
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.5
14.3
643
4710
205
Kela drug reimbursment
Chronic hypertension
1.4
14.3
793
6054
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
5.8
14.3
40
70
M79.6
ICD-10 Finland
Pain in limb
1.4
14.3
883
6874
G41.9
ICD-10 Finland
Status epilepticus, unspecified
7.2
14.3
34
48
NA7CG
NOMESCO Finland
Spine and spinal cord extensive MRI examination with high intensity magnet
5.1
14.2
44
87
N02AA05
ATC
oxycodone; systemic
1.6
14.2
406
2685
S01EC04
ATC
brinzolamide; ophthalmic
2.4
14.2
120
511
I50.0
ICD-10 Finland
Congestive heart failure
1.9
14.1
224
1246
ZXC86
NOMESCO Finland
Use of endoscopic device
7.0
14.1
34
49
H53.8
ICD-10 Finland
Other visual disturbances
6.7
14.0
35
53
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
1.8
14.0
236
1340
SPAT1260
SPAT
Consultation of another employee
1.5
13.9
468
3219
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
12.7
13.9
24
19
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
17.6
13.8
21
12
CS3P4
NOMESCO Finland
Optic nerve head stereophotography
5.1
13.8
43
86
N03AE01
ATC
clonazepam; systemic
2.1
13.7
158
776
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.7
13.6
93
352
SPAT1263
SPAT
Sampling
1.4
13.6
1097
8921
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.6
13.6
367
2389
WX882
NOMESCO Finland
High dependency care
2.7
13.6
93
353
L04AA06
ATC
mycophenolic acid; systemic
3.6
13.5
60
169
N28
ICPC
Limited function/disability (N)
3.6
13.3
59
166
SPAT1301
SPAT
No procedures
1.4
13.3
822
6389
R55
ICD-10 Finland
Syncope and collapse
1.7
13.3
294
1815
ZXE30
NOMESCO Finland
More than five and less than seven hours
2.1
13.3
157
782
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
13.2
445
3059
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.5
13.2
446
3064
H35.5
ICD-10 Finland
Hereditary retinal dystrophy
10.5
13.2
25
24
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.9
13.2
184
977
PA2LT
NOMESCO Finland
Endovascular closure of extensive brain aneurysm
9.7
13.2
26
27
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
2.0
13.2
163
827
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
6.9
13.1
32
47
R4110
NOMESCO Finland
Physiotherapy
1.4
13.1
684
5148
X59
ICD-10 Finland
Exposure to unspecified factor
1.5
13.1
460
3192
J45.9
ICD-10 Finland
Asthma, unspecified
1.5
12.9
444
3067
SPAT1296
SPAT
Other function in accordance with occupational therapy nomenclature
4.3
12.9
47
111
SPAT1245
SPAT
Provision of support and information to patient’s family members
2.2
12.9
131
611
R51
ICD-10 Finland
Headache
2.3
12.9
123
558
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.7
12.8
288
1784
P20
ICPC
Memory disturbance
1.6
12.7
323
2071
J01FA06
ATC
roxithromycin; oral
1.4
12.7
1028
8345
ZXD10
NOMESCO Finland
Scheduled procedure
1.4
12.6
1007
8146
WX002
NOMESCO Finland
Sedation and analgesia
1.5
12.6
506
3614
C09CA01
ATC
losartan; oral
1.4
12.6
628
4682
S01EA05
ATC
brimonidine; ophthalmic (sympathomimetics in glaucoma therapy)
2.8
12.6
79
285
9350/1-C75.2
ICD-O-3
Craniopharyngioma, NOS, of craniopharyngeal duct
70.1
12.6
14
*
G37.9
ICD-10 Finland
Demyelinating disease of central nervous system, unspecified
7.8
12.6
28
36
Z02.7
ICD-10 Finland
Issue of medical certificate
2.0
12.6
154
778
N05CF01
ATC
zopiclone; oral
1.4
12.5
856
6753
G40.89
ICD-10 Finland
Other epilepsy
8.7
12.5
26
30
WX110
NOMESCO Finland
Local anesthesy
1.3
12.4
1742
15337
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
1.9
12.3
194
1075
Z95.0
ICD-10 Finland
Presence of electronic cardiac devices
2.0
12.3
154
784
J01DB01
ATC
cefalexin; oral
1.4
12.3
2193
20014
XX3DW
NOMESCO Finland
Time consuming IT work
1.7
12.2
268
1649
H40.13
ICD-10 Finland
Chronic glaucoma with open ventricular angle
2.1
12.2
135
654
N05BA01
ATC
diazepam; systemic, rectal
1.6
12.2
330
2152
CKD92
NOMESCO Finland
Combined vitrectomy and retinal procedure
4.4
12.2
43
99
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.4
12.1
857
6790
ZXA05
NOMESCO Finland
Left side
1.4
12.1
671
5100
AA4DG
NOMESCO Finland
Very extensive MRI examination of sella turcica with high intensity magnet
26.8
12.0
16
6
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.4
12.0
795
6229
I60.0
ICD-10 Finland
Subarachnoid haemorrhage from carotid siphon and bifurcation
9.3
12.0
24
26
S06.0
ICD-10 Finland
Concussion
1.7
11.9
263
1621
A02BA02
ATC
ranitidine; systemic
1.5
11.9
517
3749
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
11.9
348
2312
9531/0-C70.0
ICD-O-3
Meningothelial meningioma of cerebral meninges
46.8
11.9
14
*
G40
ICD-10 Finland
Epilepsy
4.9
11.9
38
79
I65.2
ICD-10 Finland
Occlusion and stenosis of carotid artery
2.9
11.8
73
260
SPAT1297
SPAT
Other function in accordance with speech therapy nomenclature
7.4
11.7
27
37
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
7.4
11.7
27
37
I25.2
ICD-10 Finland
Old myocardial infarction
1.8
11.6
208
1201
R3120
NOMESCO Finland
Training in mobility skills
30.1
11.6
15
5
R1220
NOMESCO Finland
Psychological examination of need and possibilities to rehabilitation
5.2
11.6
35
68
E23.05
ICD-10 Finland
Lack of TSH
12.6
11.6
20
16
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
3.6
11.5
50
139
PA4AC
NOMESCO Finland
Vertebralis angiography with X-ray
11.1
11.5
21
19
PA2BG
NOMESCO Finland
MRI examination of vessels in the head with high intensity magnet
7.2
11.5
27
38
N02AJ06
ATC
codeine and paracetamol; systemic
1.3
11.5
894
7185
R11
ICD-10 Finland
Nausea and vomiting
1.8
11.4
201
1154
H34.1
ICD-10 Finland
Central retinal artery occlusion
5.8
11.3
31
54
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
8.3
11.3
24
29
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.7
11.3
252
1559
CKD40
NOMESCO Finland
Endophotocoagulation of retina
3.9
11.2
45
117
ZXE15
NOMESCO Finland
Procedure duration 120 to 149 minutes
3.2
11.2
58
185
N06AB10
ATC
escitalopram; oral
1.5
11.1
442
3143
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.4
11.1
505
3695
R1260
NOMESCO Finland
Evaluation of communicative skills
2.9
11.0
64
220
D21
ICPC
Swallowing problem
3.9
10.9
44
115
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.3
10.9
1155
9696
A02BC03
ATC
lansoprazole; oral
1.4
10.9
748
5876
G93.2
ICD-10 Finland
Benign intracranial hypertension
15.5
10.8
17
11
S06.5
ICD-10 Finland
Traumatic subdural haemorrhage
2.3
10.8
95
414
CKD65
NOMESCO Finland
Pars plana or pars plicata vitrectomy
2.8
10.8
67
240
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.6
10.8
263
1665
PA2AC
NOMESCO Finland
Cerebral angiography with X-ray
8.9
10.7
22
25
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
7.2
10.7
25
35
G91.1
ICD-10 Finland
Obstructive hydrocephalus
7.2
10.7
25
35
301
Kela drug reimbursment
Growth hormone
17.9
10.7
16
9
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.8
10.7
191
1106
H52.2
ICD-10 Finland
Astigmatism
3.9
10.7
42
108
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
7.5
10.6
24
32
A06AD11
ATC
lactulose; oral
1.5
10.6
388
2710
K78
ICPC
Atrial fibrillation/flutter
1.7
10.6
220
1333
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.6
10.6
260
1647
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.5
10.6
351
2395
AAK80
NOMESCO Finland
Partial excision of skull cap
60.2
10.6
12
*
Z02.4
ICD-10 Finland
Examination for driving licence
0.7
10.6
335
4675
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
10.6
166
921
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
10.5
358
2461
AAD15
NOMESCO Finland
Evacuation of traumatic intracerebral haematoma
14.2
10.5
17
12
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
1.4
10.5
575
4348
A12BA01
ATC
potassium chloride; oral
2.0
10.5
136
706
Q21.11
ICD-10 Finland
Paten or persistent foramen ovale
7.3
10.4
24
33
J01FF01
ATC
clindamycin; systemic
1.4
10.4
667
5176
H47.4
ICD-10 Finland
Disorders of optic chiasm
+∞
10.4
10
*
N86
ICPC
Multiple sclerosis
6.8
10.4
25
37
CHD05
NOMESCO Finland
Selective lasertrabeculoplasty
2.4
10.3
86
364
AN1
HP
Coronary angiography
1.5
10.3
329
2231
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
8.2
10.3
22
27
XF620
NOMESCO Finland
Examination of circulation with color method
6.4
10.3
26
41
FM1DE
NOMESCO Finland
Doppler ultrasound examination of heart
1.6
10.3
250
1583
AAA27
NOMESCO Finland
Insertion of intracerebral pressure monitoring device
18.8
10.2
15
8
XCH05
NOMESCO Finland
Eye pressure longterm registration
4.2
10.2
37
88
CK2A4
NOMESCO Finland
Autofluorescence imaging of ocular fundus
9.6
10.2
20
21
2273A
ICD-9 Finland
Benign neoplasm of other endocrine glands and related structures, Pituitary gland and craniopharyngeal duct (pouch)
23.4
10.2
14
6
AAL10
NOMESCO Finland
Intracranial endovascular thrombolysis
4.8
10.2
33
70
S18
ICPC
Laceration/cut
1.3
10.2
1061
8862
PA6BG
NOMESCO Finland
MRI examination of neck vasculature with high intensity magnet
7.5
10.2
23
31
C01DA14
ATC
isosorbide mononitrate; oral
1.4
10.1
445
3226
I69
ICD-10 Finland
Sequelae of cerebrovascular disease
7.9
10.1
22
28
H50.0
ICD-10 Finland
Convergent concomitant strabismus
7.9
10.1
22
28
G43.3
ICD-10 Finland
Complicated migraine
3.6
10.1
43
119
C09AA02
ATC
enalapril; systemic
1.4
10.1
530
3974
WX704
NOMESCO Finland
Intubation
1.8
10.0
178
1026
I69.2
ICD-10 Finland
Sequelae of other nontraumatic intracranial haemorrhage
11.3
10.0
18
16
280
Kela drug reimbursment
Clopidogrel
2.9
10.0
59
206
J01DA01
ATC
[U] cefalexin; systemic
1.3
10.0
1621
14345
CA1BG
NOMESCO Finland
Eye and orbita MRI examination with high intensity magnet
10.1
10.0
19
19
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
9.1
10.0
20
22
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
14.6
10.0
16
11
D32.03
ICD-10 Finland
Benign meningioma in ventricles
14.6
10.0
16
11
H50.1
ICD-10 Finland
Divergent concomitant strabismus
6.1
10.0
26
43
C71.43
ICD-10 Finland
Malignant tumor of the occipital lobe grade IV glioma
40.2
10.0
12
*
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
1.9
9.9
153
843
H57.1
ICD-10 Finland
Ocular pain
2.4
9.9
78
324
N05AH04
ATC
quetiapine; oral
1.5
9.9
369
2590
A04
ICPC
Weakness/tiredness general
1.5
9.8
319
2166
I60.7
ICD-10 Finland
Subarachnoid haemorrhage from intracranial artery, unspecified
8.1
9.8
21
26
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.7
9.8
197
1183
A49.9
ICD-10 Finland
Bacterial infection, unspecified
1.6
9.8
285
1887
PA2YT
NOMESCO Finland
Cerebral artery PTA with stent
9.5
9.7
19
20
C01DA02
ATC
glyceryl trinitrate; oral, oral aerosol, sublingual, transdermal
1.4
9.7
558
4248
N88
ICPC
Epilepsy
5.8
9.6
26
45
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.0
9.6
123
634
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.5
9.6
321
2194
M79.1
ICD-10 Finland
Myalgia
1.6
9.6
284
1889
I60.2
ICD-10 Finland
Subarachnoid haemorrhage from anterior communicating artery
6.4
9.5
24
38
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
9.1
9.5
19
21
M31.5
ICD-10 Finland
Giant cell arteritis with polymyalgia rheumatica
3.9
9.5
37
95
PA3AC
NOMESCO Finland
Carotis angiography with X-ray
7.1
9.5
22
31
R51.81
ICD-10 Finland
Facial pain NOS
2.9
9.5
56
197
H57.9
ICD-10 Finland
Disorder of eye and adnexa, unspecified
4.2
9.5
34
81
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.0
9.4
113
568
N04BC06
ATC
cabergoline; oral (dopamine agonists)
6.6
9.4
23
35
SPAT1153
SPAT
Removal of sutures
1.3
9.4
800
6479
TKC20
NOMESCO Finland
Catheterisation of bladder
1.7
9.4
191
1151
ZX050
NOMESCO Finland
Stereotactic radiotherapy
5.1
9.4
28
55
A46
ICD-10 Finland
Erysipelas
1.5
9.4
353
2479
AAK00
NOMESCO Finland
Cranioplasty
21.7
9.3
13
6
81
HP
Angiography of the heart and coronary arteries
1.7
9.3
191
1155
A02BC05
ATC
esomeprazole; systemic
1.3
9.3
996
8325
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
9.3
650
5106
R06AE07
ATC
cetirizine; oral
1.3
9.3
1019
8543
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
8.7
9.3
19
22
XFP20
NOMESCO Finland
Check up of cardiac pacemaker
1.7
9.3
183
1092
SPAT1053
SPAT
Memory test
1.4
9.2
391
2810
CS1H4
NOMESCO Finland
Retinal nerve fibre layer imaging
3.3
9.2
44
134
H02.4
ICD-10 Finland
Ptosis of eyelid
2.4
9.2
77
331
H35.6
ICD-10 Finland
Retinal haemorrhage
5.5
9.2
26
48
H43.8
ICD-10 Finland
Other disorders of vitreous body
1.7
9.2
204
1259
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.8
9.2
149
838
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
13.7
9.2
15
11
I21.49
ICD-10 Finland
Acute subendocardial infarction unspecified coronary artery status
1.8
9.2
158
907
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
1.8
9.1
152
859
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.1
9.1
102
500
S06.3
ICD-10 Finland
Focal brain injury
3.5
9.1
40
114
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
9.0
375
2686
Z50.9
ICD-10 Finland
Care involving use of rehabilitation procedure, unspecified
2.1
9.0
99
482
AAC40
NOMESCO Finland
Extirpation of intracranial arterio-venous malformation
36.8
9.0
11
*
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.9
9.0
126
674
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.4
9.0
418
3061
S01EE03
ATC
bimatoprost; ophthalmic
2.5
8.9
66
266
E23.01
ICD-10 Finland
Isolated deficiency of growth hormone
24.1
8.9
12
5
G81.1
ICD-10 Finland
Spastic hemiplegia
12.5
8.9
15
12
L04AX01
ATC
azathioprine; systemic
2.1
8.8
100
493
C10AA07
ATC
rosuvastatin; oral
1.4
8.8
576
4470
RS221
NOMESCO Finland
NA
3.3
8.8
43
133
W19
ICD-10 Finland
Unspecified fall
1.6
8.8
234
1516
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
1.9
8.8
131
715
R60.0
ICD-10 Finland
Localized oedema
1.5
8.8
268
1796
H25.0
ICD-10 Finland
Senile incipient cataract
1.8
8.7
154
889
C03DA01
ATC
spironolactone; oral
1.5
8.7
276
1866
ZXC40
NOMESCO Finland
Use of ultrasound
4.4
8.7
30
69
Z2221
NOMESCO Finland
Medical doctor
1.3
8.7
683
5455
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
50.1
8.7
10
*
F32.11
ICD-10 Finland
Moderate depressive episode with somatic syndrome
2.5
8.7
66
268
PA6CG
NOMESCO Finland
Extensive MRI examination of neck vasculature with high intensity magnet
7.6
8.6
19
25
H43.3
ICD-10 Finland
Other vitreous opacities
3.5
8.6
38
109
PA6AD
NOMESCO Finland
CT of neck arteries
3.4
8.6
40
120
PAW37
NOMESCO Finland
Biopsy of temporal artery
4.6
8.6
28
61
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
9.0
8.5
17
19
N06AA09
ATC
amitriptyline; systemic
1.6
8.5
235
1537
N30.9
ICD-10 Finland
Cystitis, unspecified
1.8
8.5
130
718
E78.01
ICD-10 Finland
Pure hypercholesterolaemia
1.4
8.5
486
3692
2151
FHL
Resection, big brain
27.6
8.5
11
*
G80.2
ICD-10 Finland
Spastic hemiplegic cerebral palsy
20.1
8.5
12
6
H26.02
ICD-10 Finland
Presenil cataract
2.5
8.4
65
267
K89
ICPC
Transient cerebral ischaemia
4.0
8.4
32
81
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.5
8.4
277
1890
H54.0
ICD-10 Finland
Blindness, binocular
90.3
8.4
9
*
L04AA31
ATC
teriflunomide; oral
12.8
8.4
14
11
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
12.8
8.4
14
11
AA4AD
NOMESCO Finland
CT of sella turcica
+∞
8.3
8
*
D35.3
ICD-10 Finland
Benign neoplasm: Craniopharyngeal duct
+∞
8.3
8
*
R4130
NOMESCO Finland
Speech therapy
2.5
8.3
64
262
H02AB04
ATC
methylprednisolone; systemic
1.4
8.3
348
2495
AAF15
NOMESCO Finland
Ventriculoatrial shunt
10.8
8.3
15
14
N99
ICPC
Neurological disease other
3.4
8.2
38
114
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.3
8.2
1039
8839
R04.0
ICD-10 Finland
Epistaxis
1.6
8.2
186
1159
3454A
ICD-9 Finland
Epilepsy, Partial epilepsy, with impairment of consciousness[EPILEPSIA GENERALISATA SECUNDARIA]
7.5
8.1
18
24
E22.1
ICD-10 Finland
Hyperprolactinaemia
4.7
8.1
26
56
L17
ICPC
Foot/toe symptom/complaint
1.3
8.1
597
4719
PA2HT
NOMESCO Finland
Extensive embolisation of arterio-venous malformation of the brain
33.4
8.1
10
*
SPAT1234
SPAT
Support of social functional capacity
1.8
8.1
130
730
S01EE05
ATC
tafluprost; ophthalmic
2.1
8.0
91
447
ZXY02
NOMESCO Finland
Neuropsychologist
4.8
8.0
25
52
206
Kela drug reimbursment
Chronic coronary artery disease and dyslipidaemia associated with chronic coronary artery disease
1.4
8.0
497
3819
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
8.9
8.0
16
18
H25.8
ICD-10 Finland
Other senile cataract
1.5
8.0
265
1811
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
22.1
8.0
11
5
J01MA02
ATC
ciprofloxacin; systemic
1.3
8.0
984
8331
C10AA03
ATC
pravastatin; oral
1.6
8.0
183
1143
L03AB07
ATC
interferon beta-1a; parenteral
6.3
8.0
20
32
G50.1
ICD-10 Finland
Atypical facial pain
2.9
8.0
47
166
4340A
ICD-9 Finland
Occlusion of cerebral arteries, Cerebral thrombosis
3.5
7.9
35
101
H02AB07
ATC
prednisone; oral
1.4
7.9
335
2404
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.3
7.9
623
4971
C09CA06
ATC
candesartan; oral
1.4
7.9
502
3879
J45.0
ICD-10 Finland
Predominantly allergic asthma
1.6
7.9
183
1146
I50.1
ICD-10 Finland
Left ventricular failure
1.8
7.8
126
706
ZXD35
NOMESCO Finland
Usual procedure
2.0
7.8
90
449
C71.23
ICD-10 Finland
Malignant tumor of temporal lobe grade IV glioma
10.8
7.8
14
13
H51.1
ICD-10 Finland
Convergence insufficiency and excess
10.8
7.8
14
13
H02AB02
ATC
dexamethasone; systemic
1.5
7.8
246
1665
J01AA02
ATC
doxycycline; systemic
1.3
7.7
2037
18817
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
1.8
7.7
133
765
I25.0
ICD-10 Finland
Atherosclerotic cardiovascular disease, so described
1.7
7.7
155
932
H35.30
ICD-10 Finland
Kuhnt-Junius degeneration
1.8
7.7
125
705
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
5.9
7.7
20
34
I69.8
ICD-10 Finland
Sequelae of other and unspecified cerebrovascular diseases
5.6
7.7
21
38
PA2KT
NOMESCO Finland
Endovascular closure of brain aneurysm
7.4
7.7
17
23
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.5
7.7
236
1586
S01EC01
ATC
acetazolamide; systemic
2.4
7.6
60
250
C08CA13
ATC
lercanidipine; oral
1.4
7.6
319
2284
G50.0
ICD-10 Finland
Trigeminal neuralgia
2.8
7.6
45
160
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.3
7.6
920
7763
M03BX02
ATC
tizanidine; oral
1.2
7.6
1468
13082
R2120
NOMESCO Finland
Counselling and guidance concerning rehabilitation services and social security
4.2
7.6
27
65
H53.3
ICD-10 Finland
Other disorders of binocular vision
11.9
7.6
13
11
A10AE04
ATC
insulin glargine; parenteral
1.5
7.6
226
1508
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
4.5
7.5
25
56
O99.3
ICD-10 Finland
Mental disorders and diseases of the nervous system complicating pregnancy, childbirth and the puerperium
3.7
7.5
31
85
J01CA04
ATC
amoxicillin; systemic
1.3
7.5
2089
19385
R02
ICPC
Shortness of breath/dyspnoea
1.5
7.5
284
1999
D68.8
ICD-10 Finland
Other specified coagulation defects
3.7
7.4
30
81
127
Kela drug reimbursment
Transplant complication
2.9
7.4
43
150
R03AC02
ATC
salbutamol; inhalant
1.2
7.4
1274
11193
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.6
7.4
188
1205
AAK85
NOMESCO Finland
Replantation of previously excised part of skull cap
80.3
7.4
8
*
XA412
NOMESCO Finland
VEP
80.3
7.4
8
*
H26.2
ICD-10 Finland
Complicated cataract
3.4
7.4
34
102
SPAT1252
SPAT
Overall medication plan or its review
1.6
7.4
183
1166
G46.4*I67.9
ICD-10 Finland
Cerebellar stroke syndrome
5.0
7.4
22
44
SPAT1292
SPAT
Other function in accordance with SHToL (Finnish classification of nursing interventions)
1.5
7.4
214
1420
E78.00
ICD-10 Finland
Familial hypercholesterolaemia
1.9
7.4
107
579
N80
ICPC
Head injury other
2.8
7.4
45
164
C71.30
ICD-10 Finland
Malignant tumor in parietal lobe without histology
13.4
7.4
12
9
N76
ICPC
Neoplasm nervous system unspecified
13.4
7.4
12
9
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
1.7
7.4
145
868
Z95.1
ICD-10 Finland
Presence of aortocoronary bypass graft
1.8
7.3
122
694
SPAT1100
SPAT
Long-term monitoring of blood pressure
1.6
7.3
171
1073
N05CD07
ATC
temazepam; oral
1.4
7.3
301
2151
9400/3-C71.2
ICD-O-3
Astrocytoma, NOS, of temporal lobe
+∞
7.3
7
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.5
7.3
214
1423
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.3
7.3
949
8074
L03AX13
ATC
glatiramer acetate; parenteral
6.8
7.3
17
25
SPAT1251
SPAT
Organisation of medication
1.9
7.3
98
517
R13
ICD-10 Finland
Dysphagia
1.7
7.3
153
936
Z94.0
ICD-10 Finland
Kidney transplant status
3.5
7.3
32
93
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.5
7.3
273
1918
S22
ICPC
Nail symptom/complaint
1.7
7.2
132
773
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.5
7.2
264
1841
ZXM40
NOMESCO Finland
Use of fluorescent substance
15.8
7.2
11
7
I60.8
ICD-10 Finland
Other subarachnoid haemorrhage
15.8
7.2
11
7
N05BA04
ATC
oxazepam; oral
1.3
7.2
586
4687
GBB00
NOMESCO Finland
Tracheostomy
3.1
7.1
36
116
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
7.1
957
8163
R41.3
ICD-10 Finland
Other amnesia
2.1
7.1
75
358
I34.09
ICD-10 Finland
Mitral (valve) insufficiency
1.9
7.1
101
547
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.6
7.1
167
1052
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
1.6
7.1
178
1139
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
12.0
7.1
12
10
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.4
7.1
310
2244
CKD10
NOMESCO Finland
Insufflation of vitreous cavity
2.7
7.1
46
174
G40.4
ICD-10 Finland
Other generalized epilepsy and epileptic syndromes
8.8
7.0
14
16
SPAT1262
SPAT
Handing over of treatment supplies
1.4
7.0
439
3378
N03AX22
ATC
perampanel; oral
10.0
7.0
13
13
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
1.8
7.0
121
697
B01AF02
ATC
apixaban; oral
1.5
7.0
243
1677
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.6
7.0
155
959
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.5
7.0
231
1581
NA7BG
NOMESCO Finland
Spine and spinal cord MRI examination with high intensity magnet
4.9
7.0
21
43
PA2AD
NOMESCO Finland
CT angiography of brain
4.9
7.0
21
43
Z50.1
ICD-10 Finland
Other physical therapy
1.7
6.9
131
776
N31.9
ICD-10 Finland
Neuromuscular dysfunction of bladder, unspecified
3.7
6.9
28
76
SPAT1101
SPAT
Orthostatic test
1.8
6.9
113
641
K59.1
ICD-10 Finland
Functional diarrhoea
1.8
6.9
113
641
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
6.9
165
1042
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
13.8
6.9
11
8
N74
ICPC
Malignant neoplasm nervous system
13.8
6.9
11
8
PA6AG
NOMESCO Finland
Limited MRI examination of neck vasculature with high intensity magnet
4.6
6.9
22
48
CKD05
NOMESCO Finland
Puncture of vitreous body with injection of medication
1.8
6.9
111
628
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
6.9
480
3757
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.8
6.9
103
567
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
6.9
771
6432
ZY010
NOMESCO Finland
Hospital outpatient
1.9
6.9
101
553
C01AA05
ATC
digoxin; systemic
1.5
6.9
212
1426
SAA03
NOMESCO Finland
Extended examination of mouth
1.3
6.9
854
7216
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.6
6.8
155
968
CS2P4
NOMESCO Finland
Optic nerve head imaging
4.8
6.8
21
44
I20.81
ICD-10 Finland
Other angina pectoris stenosed coronary artery
1.5
6.8
216
1460
AA9CW
NOMESCO Finland
NA
8.3
6.8
14
17
A06AC01
ATC
ispaghula (psylla seeds); oral
1.3
6.8
554
4433
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
1.6
6.8
174
1122
SPAT1325
SPAT
Vaccination
1.3
6.8
863
7307
H20.0
ICD-10 Finland
Acute and subacute iridocyclitis
1.9
6.8
90
473
S01EC54
ATC
brinzolamide, combinations; ophthalmic
2.9
6.8
39
136
PAF14
NOMESCO Finland
Thrombendarterectomy of internal carotid artery
2.5
6.8
48
191
N05CD08
ATC
midazolam; nasal, systemic
2.3
6.8
60
267
H52.5
ICD-10 Finland
Disorders of accommodation
40.1
6.8
8
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
16.7
6.7
10
6
ZXE17
NOMESCO Finland
Procedure duration 150 to 179 minutes
3.3
6.7
31
94
FN1BC
NOMESCO Finland
Extensive angiography of hear and/or coronary arteries
1.7
6.7
134
807
EBA10
NOMESCO Finland
Surgical removal of tooth
1.5
6.7
225
1545
H54.5
ICD-10 Finland
Severe visual impairment, monocular
7.2
6.7
15
21
I61.8
ICD-10 Finland
Other intracerebral haemorrhage
7.2
6.7
15
21
RS222
NOMESCO Finland
NA
3.1
6.7
34
111
L16
ICPC
Ankle symptom/complaint
1.5
6.7
220
1504
A03
ICPC
Fever
1.4
6.6
319
2347
I34.1
ICD-10 Finland
Mitral (valve) prolapse
2.2
6.6
62
283
M54.5
ICD-10 Finland
Low back pain
1.3
6.6
730
6072
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.5
6.6
208
1408
WF099
NOMESCO Finland
Other radiotherapy
4.2
6.6
23
55
ZXA00
NOMESCO Finland
Right side
1.3
6.6
659
5416
D35.31
ICD-10 Finland
Cyst in Rathke's pocket
12.3
6.6
11
9
L03AB08
ATC
interferon beta-1b; parenteral
12.3
6.6
11
9
G97.0
ICD-10 Finland
Cerebrospinal fluid leak from spinal puncture
3.3
6.6
31
96
164
Kela drug reimbursment
Fingolimod
8.7
6.5
13
15
R35
ICD-10 Finland
Polyuria
1.6
6.5
149
933
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.7
6.5
120
704
FFC22
NOMESCO Finland
Percutaneous transluminal closure of ostium secundum type ASD
10.0
6.5
12
12
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
6.5
382
2910
K59.09
ICD-10 Finland
Constipation, unspecified
1.6
6.5
145
899
G02CB01
ATC
bromocriptine; systemic
2.7
6.5
40
148
C08DB01
ATC
diltiazem; oral
1.7
6.5
132
801
U04
ICPC
Incontinence urine
1.8
6.5
111
640
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
1.6
6.5
170
1102
H35.4
ICD-10 Finland
Peripheral retinal degeneration
3.8
6.5
25
66
S01GX01
ATC
cromoglicic acid; ophthalmic
1.3
6.5
400
3073
9440/3-C71.4
ICD-O-3
Glioblastoma, NOS, of occipital lobe
70.0
6.4
7
*
N04BB01
ATC
amantadine; oral
2.6
6.4
43
167
H50.31
ICD-10 Finland
Intermittent exotropia
4.3
6.4
22
52
P01AB01
ATC
metronidazole; oral, rectal
1.2
6.4
909
7785
J01FA10
ATC
azithromycin; systemic
1.2
6.4
1333
11894
SPAT1211
SPAT
Application of soft bandage
1.5
6.4
205
1396
M01AE03
ATC
ketoprofen; systemic, rectal
1.2
6.3
924
7936
H43.1
ICD-10 Finland
Vitreous haemorrhage
2.2
6.3
57
256
E11.00
ICD-10 Finland
Non-insulin dependent diabetes diabetic hypoglycaemic coma
1.9
6.3
85
453
B01AB04
ATC
dalteparin; parenteral
1.7
6.3
125
752
WX730
NOMESCO Finland
Conventional respirator
2.6
6.3
43
169
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.6
6.3
143
892
M32.9
ICD-10 Finland
Systemic lupus erythematosus, unspecified
4.2
6.3
22
53
I64
ICD-10 Finland
Stroke, not specified as haemorrhage or infarction
4.2
6.3
22
53
G91.8
ICD-10 Finland
Other hydrocephalus
11.0
6.3
11
10
G46.3*I67.9
ICD-10 Finland
Brain stem stroke syndrome (I60-I67+)
5.5
6.3
17
31
D32.05
ICD-10 Finland
Cerebral meninges
9.3
6.3
12
13
C71.2
ICD-10 Finland
Malignant neoplasm: Temporal lobe
9.3
6.3
12
13
UKC02
NOMESCO Finland
Cystoscopy
1.3
6.3
406
3140
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
4.0
6.3
23
58
M04AA01
ATC
allopurinol; systemic
1.4
6.3
324
2415
RK322
NOMESCO Finland
NA
18.0
6.3
9
5
C72.3
ICD-10 Finland
Malignant neoplasm: Optic nerve
+∞
6.2
6
*
C71.4
ICD-10 Finland
Malignant neoplasm: Occipital lobe
26.7
6.2
8
*
H53.5
ICD-10 Finland
Colour vision deficiencies
26.7
6.2
8
*
9380/3-C71.9
ICD-O-3
Glioma, malignant of brain, NOS
26.7
6.2
8
*
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.1
6.2
62
294
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.3
6.2
412
3197
A02BA04
ATC
nizatidine; systemic
1.5
6.2
187
1256
WX402
NOMESCO Finland
General anaesthesia
1.4
6.2
368
2808
R52.2
ICD-10 Finland
Other chronic pain
2.0
6.2
77
398
X58
ICD-10 Finland
Exposure to other specified factors
1.4
6.1
300
2212
S01EC03
ATC
dorzolamide; ophthalmic
2.7
6.1
38
142
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
7.7
6.1
13
17
L04AX07
ATC
dimethyl fumarate; oral
7.7
6.1
13
17
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
12.5
6.1
10
8
PA6AM
NOMESCO Finland
Simple MRI examination of neck vasculature with 3 Tesla magnet
12.5
6.1
10
8
Q85.00
ICD-10 Finland
Neurofibromatosis, type 1
12.5
6.1
10
8
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
1.8
6.1
98
554
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.4
6.1
241
1713
A01
ICPC
Pain general/multiple sites
1.6
6.0
164
1074
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
10.0
6.0
11
11
R90.0
ICD-10 Finland
Intracranial space-occupying lesion
10.0
6.0
11
11
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.7
6.0
112
663
XF600
NOMESCO Finland
Bloodpressure measurement
1.6
6.0
145
921
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.6
6.0
145
921
F43.29
ICD-10 Finland
Adaptation disorder UNS
2.5
6.0
44
180

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1508
8139
2.56
148.56
2.6
2.1
u/l
166.7
240.9
2.68
1433
7608
(3018677) aPTT in Platelet poor plasma by Coagulation assay
930
4171
2.71
131.34
2.8
2.1
s
29.4
29.9
2.44
898
4047
(3032080) INR in Blood by Coagulation assay
1747
11306
2.15
99.52
14.0
10.0
inr
1.6
1.3
0.72
560
3231
(3013826) Glucose [Moles/volume] in Serum or Plasma
2191
15948
2.10
85.63
6.6
4.7
mmol/l
6.6
6.8
3.41
2098
14926
(3036481) Cortisol [Moles/volume] in Serum or Plasma
525
2378
2.43
68.10
3.4
2.1
nmol/l
357.0
371.8
0.43
482
2169
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1750
12379
1.87
66.86
7.6
6.0
mmol/l
1.2
1.2
4.89
1606
11176
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1879
13679
1.86
64.63
8.4
6.8
mmol/l
1.2
1.2
3.34
1550
11481
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
104
162
6.59
63.93
1.7
1.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
185
486
3.97
62.16
1.7
1.4
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
226
720
3.29
56.79
3.4
1.5
mu/l
352.2
308.7
0.76
213
657
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
200
608
3.44
54.12
1.6
1.3
mg/l
627.7
542.9
0.66
191
576
(3003396) Base excess in Arterial blood by calculation
611
3243
2.08
52.85
7.9
7.3
mmol/l
0.9
1.2
0.78
473
2516
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
611
3252
2.08
52.42
7.9
7.3
kpa
5.0
5.1
1.25
579
3088
(3027801) Oxygen [Partial pressure] in Arterial blood
610
3252
2.07
52.08
7.9
7.3
kpa
13.5
12.1
6.02
575
3085
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1471
10462
1.73
49.88
4.9
3.7
ng/l
86.6
55.1
0.38
1107
7409
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
178
531
3.49
49.57
1.7
1.4
e6/l
16.9
28.3
0.45
145
416
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
178
531
3.49
49.57
1.7
1.5
e6/l
1321.7
1520.6
0.09
153
439
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
112
238
4.84
49.40
1.8
1.6
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1165
7795
1.76
48.83
4.7
4.3
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
175
543
3.35
45.79
1.4
1.3
mmol/l
3.7
3.9
1.63
161
515
(3036489) Thrombin time
249
952
2.75
45.16
2.8
2.0
s
21.5
21.6
0.13
205
849
(3018418) pH of Serum or Plasma
1187
8124
1.72
45.02
4.6
4.0
ph
7.4
7.4
0.30
275
1555
(3033658) Prothrombin time (PT) actual/Normal
1027
6804
1.74
43.49
4.8
4.0
%
88.5
88.1
0.20
1000
6631
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
71
112
6.46
43.11
2.5
2.1
umol/l
59.2
52.6
0.73
56
90
(3024561) Albumin [Mass/volume] in Serum or Plasma
1595
11914
1.65
42.64
5.4
4.8
g/l
35.0
35.2
0.43
1492
11060
(3016018) Differential panel - Cerebral spinal fluid
105
239
4.50
42.59
1.6
1.4
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
727
4482
1.80
38.85
3.8
3.3
mmol/l
0.8
0.8
0.48
676
4172
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
746
4639
1.78
38.70
2.0
1.8
—
—
—
0
0
(3035999) Lactate [Moles/volume] in Cerebral spinal fluid
87
185
4.80
38.35
1.6
1.3
mmol/l
2.2
2.0
0.43
81
176
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
83
170
4.98
38.24
1.1
1.1
mg/l
47.9
39.6
0.69
63
144
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
38
32
12.00
37.67
2.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
79
160
5.03
36.88
1.1
1.1
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
80
165
4.94
36.57
1.1
1.1
mg/l
265.8
274.3
0.14
65
144
(3016502) Oxygen saturation in Arterial blood
512
2893
1.91
35.90
8.8
7.7
%
95.9
95.6
0.64
487
2778
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
29
17
17.20
35.02
1.1
1.0
—
—
—
0
0
(4027681)
68
127
5.45
34.75
1.4
1.2
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
476
2657
1.92
34.54
9.3
8.1
g/l
121.5
120.9
0.23
453
2555
(3031040) Bacteria [#/volume] in Urine by Automated count
2155
17845
1.59
33.97
5.7
4.6
e6/l
3117.7
1964.1
0.21
27
276
(42870588) Differential panel, method unspecified - Blood
1245
9123
1.58
33.43
7.1
5.7
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
1154
8330
1.59
32.92
3.7
3.2
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1777
14144
1.55
32.83
6.5
6.1
umol/l
11.1
11.8
1.90
1651
13417
(3006315) Basophils [#/volume] in Blood
1687
13292
1.55
32.51
6.8
5.7
e9/l
0.0
0.0
0.46
1497
11424
(3001604) Monocytes [#/volume] in Blood
1680
13238
1.54
32.27
6.8
5.7
e9/l
0.6
0.6
0.39
1492
11369
(3013115) Eosinophils [#/volume] in Blood
1732
13745
1.54
32.16
7.0
5.9
e9/l
0.2
0.2
0.65
1542
11986
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2424
20766
1.62
31.94
8.7
7.5
u/l
80.2
79.4
0.26
2268
19537
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
65
126
5.24
31.90
1.8
1.7
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
348
1803
2.04
31.14
8.7
7.0
mmol/l
24.7
24.6
0.36
320
1673
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
194
791
2.54
30.79
3.6
2.2
%
96.3
90.9
2.92
175
748
(3019198) Lymphocytes [#/volume] in Blood
1702
13590
1.52
29.77
6.8
5.8
e9/l
1.8
1.9
1.52
1524
11911
(3023410) Appearance of Cerebral spinal fluid
88
232
3.87
29.42
1.7
1.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
587
3678
1.72
28.71
6.5
5.8
mmol/l
1.0
1.0
0.22
548
3407
(3009466) Valproate [Moles/volume] in Serum or Plasma
117
378
3.17
28.66
3.8
5.1
umol/l
346.9
352.6
0.14
102
330
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
530
3231
1.76
28.55
1.9
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
527
3223
1.75
28.04
1.9
1.7
—
—
—
0
0
(3019060) Gas panel - Arterial blood
352
1899
1.95
27.97
6.6
5.0
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
2302
19725
1.54
27.95
4.7
4.0
mm/h
13.2
12.8
0.55
2146
18184
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1116
8235
1.53
27.73
3.5
3.1
ng/l
1851.6
1639.1
0.73
952
7085
(3019309) Folate [Moles/volume] in Red Blood Cells
790
5394
1.61
27.57
1.9
1.8
nmol/l
1170.0
1173.6
0.04
598
4062
(3020779) Urea [Moles/volume] in Serum or Plasma
434
2539
1.82
26.77
7.7
7.3
mmol/l
9.3
10.3
1.95
400
2411
(3037467) Urinalysis macro (dipstick) panel - Urine
2179
18531
1.51
26.71
5.4
4.4
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
784
5379
1.60
26.68
4.7
3.8
ng/l
226.8
589.3
1.17
602
4334
(3022217) INR in Platelet poor plasma by Coagulation assay
582
3718
1.69
26.29
32.0
26.0
inr
1.6
1.4
0.89
73
526
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
80
217
3.75
25.71
1.0
1.1
—
—
—
0
0
(3019069) Monocytes/100 leukocytes in Blood
1565
12521
1.47
25.58
7.5
6.2
%
8.8
8.7
0.39
1497
11703
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
170
711
2.47
25.56
3.3
2.5
%
183.7
191.4
0.49
162
682
(3014576) Chloride [Moles/volume] in Serum or Plasma
551
3509
1.68
25.08
6.7
6.7
mmol/l
104.8
104.3
1.30
536
3425
(3006504) Eosinophils/100 leukocytes in Blood
1555
12459
1.47
25.03
7.3
5.9
%
2.8
2.8
0.57
1485
11594
(3013650) Neutrophils [#/volume] in Blood by Automated count
1861
15439
1.47
24.98
9.6
8.8
e9/l
4.3
4.2
1.49
1663
13439
(3026782) Osmolality of Urine
788
5503
1.57
24.56
3.2
2.8
mosm/kgh2o
525.1
552.3
2.78
700
4684
(3022096) Basophils/100 leukocytes in Blood
1513
12107
1.46
24.24
7.3
6.0
%
0.6
0.7
0.61
1443
11276
(4306422)
104
352
3.02
23.57
1.2
1.2
—
—
—
0
0
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
48
94
5.17
23.33
3.5
2.7
umol/l
30.4
28.5
0.47
41
69
(3030467) Casts [#/volume] in Urine by Automated count
1025
7649
1.49
23.21
3.9
3.2
e6/l
0.5
0.5
0.05
822
5812
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
58
135
4.35
22.95
1.1
1.2
ratio
1.1
1.0
0.73
14
57
(3002030) Lymphocytes/100 leukocytes in Blood
1580
12832
1.44
22.92
7.4
6.0
%
26.2
27.2
3.34
1503
11925
(3018010) Neutrophils/100 leukocytes in Blood
1558
12632
1.44
22.75
7.0
5.8
%
58.9
57.8
3.22
1485
11804
(36304419) Bacteria [Presence] in Urine
996
7427
1.49
22.49
3.8
3.1
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
410
2477
1.75
22.46
2.5
2.4
ug/l
5.5
6.9
1.33
350
2163
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
55
125
4.46
22.43
1.1
1.1
u/l
1.3
1.2
0.15
27
63
(3008295) Osmolality of Serum or Plasma
89
288
3.15
21.80
1.7
1.4
mosm/kgh2o
283.0
278.6
1.03
77
218
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
968
7229
1.48
21.51
2.5
2.2
mg/l
3.0
3.0
0.03
824
6142
(3019550) Sodium [Moles/volume] in Serum or Plasma
2961
27421
1.73
21.18
25.7
17.4
mmol/l
139.5
139.6
2.46
2897
26708
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
102
365
2.85
20.95
1.3
1.2
u/ml
5.5
4.0
0.41
44
160
(3022948) Iron [Moles/volume] in Serum or Plasma
642
4418
1.56
20.93
2.8
2.5
umol/l
12.0
12.8
1.87
579
4084
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
99
349
2.89
20.90
1.1
1.1
%
122.0
114.9
1.40
93
323
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
2887
26585
1.65
20.77
21.5
14.9
mg/l
23.3
25.0
2.18
2452
21262
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1099
8455
1.45
20.76
3.0
2.5
u/l
60.4
58.0
0.18
1010
7786
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2287
20069
1.45
20.60
4.7
3.9
pmol/l
14.9
14.8
0.33
2069
18183
(3047181) Lactate [Moles/volume] in Blood
189
908
2.15
20.54
8.8
6.7
mmol/l
1.3
1.3
0.04
165
789
(3039000) Anion gap in Blood
149
650
2.35
20.43
9.9
7.8
mmol/l
11.1
11.3
0.28
132
579
(3018572) Chloride [Moles/volume] in Blood
149
651
2.35
20.36
9.9
7.8
mmol/l
104.7
105.1
0.30
132
580
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
42
83
5.11
20.23
1.1
1.0
—
—
—
0
0
(3023103) Potassium [Moles/volume] in Serum or Plasma
2962
27495
1.71
20.19
25.8
17.5
mmol/l
4.0
4.0
1.39
2894
26737
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
793
5752
1.50
20.15
2.2
1.7
mg/l
1.2
1.3
0.15
597
4432
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1403
11329
1.41
20.08
2.1
2.0
pmol/l
95.4
94.2
0.41
753
5928
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
32
49
6.58
20.01
1.3
1.2
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
201
1000
2.07
19.94
4.2
2.9
u/ml
0.4
0.3
1.07
116
573
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1542
12670
1.40
19.89
4.6
4.1
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
267
1469
1.89
19.84
9.0
9.4
mmol/l
23.9
24.3
1.30
255
1376
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
55
138
4.04
19.76
1.1
1.1
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
77
243
3.22
19.69
2.5
1.5
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
805
5884
1.49
19.61
3.2
2.6
e6/l
4.8
5.4
0.84
731
5179
(3002582) Erythrocytes [#/volume] in Urine
1084
8393
1.43
19.50
4.1
3.3
e6/l
64.8
86.7
0.75
884
6489
(3009214) Lutropin [Units/volume] in Serum or Plasma
138
598
2.36
19.22
2.0
1.4
u/l
9.5
9.9
0.10
103
487
(3007930) Methemoglobin/Hemoglobin.total in Blood
224
1178
1.97
19.04
7.8
5.6
%
0.9
0.9
0.08
206
1103
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
45
100
4.55
18.90
1.0
1.1
%
95.9
93.5
0.20
38
81
(3044640) Blood type and Crossmatch panel - Blood
1105
8637
1.42
18.67
2.8
2.5
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
325
1936
1.75
18.58
3.0
2.7
g/l
10.5
10.6
0.08
292
1761
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
335
2023
1.73
18.24
1.7
1.6
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2654
24157
1.49
18.19
5.4
4.6
mu/l
1.9
2.1
1.34
2404
22003
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1344
10911
1.39
18.02
2.5
2.2
nmol/l
76.1
78.0
1.70
1218
9717
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
297
1741
1.78
17.94
9.5
9.0
%
0.7
0.7
0.61
297
1726
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
222
1189
1.93
17.88
7.8
5.6
%
1.8
1.6
0.69
203
1113
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
188
951
2.04
17.83
2.2
2.3
ug/l
357.1
547.4
1.09
180
893
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
269
1535
1.82
17.78
11.7
10.1
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
585
4081
1.53
17.63
2.9
2.5
g/l
2.3
2.3
0.32
531
3767
(3003181) Sodium [Moles/volume] in Urine
115
478
2.46
17.58
1.7
1.3
mmol/l
75.1
62.2
1.92
100
379
(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood
297
1753
1.76
17.51
9.3
8.9
%
1.5
1.3
1.30
297
1741
(3051593) INR in Capillary blood by Coagulation assay
52
137
3.84
17.50
10.3
14.9
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1211
9707
1.39
17.34
4.7
3.7
e6/l
99.9
113.2
0.21
925
6945
(3035637) Corticotropin [Mass/volume] in Plasma
83
298
2.83
17.00
2.0
1.4
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
50
131
3.86
16.97
1.2
1.1
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
93
355
2.67
16.95
1.1
1.1
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
158
765
2.12
16.85
3.9
2.4
g/l
3.4
3.6
0.71
150
717
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
148
699
2.17
16.82
2.0
1.6
g/l
0.2
0.2
0.55
139
661
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
97
380
2.60
16.79
1.3
1.2
u/ml
7.3
2.4
0.78
28
130
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
151
724
2.14
16.52
2.0
1.6
g/l
1.2
1.2
0.08
141
684
(3009445) Proteinase 3 Ab [Units/volume] in Serum
208
1120
1.91
16.49
1.5
1.4
u/ml
25.8
20.1
—
6
25
(3009261) Glucose [Presence] in Urine by Test strip
1575
13247
1.36
16.39
4.6
3.7
estimate
0.0
0.0
1.32
340
2391
(3035350) Ketones [Presence] in Urine by Test strip
1557
13074
1.36
16.37
4.6
3.7
estimate
0.0
0.0
0.00
353
2439
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
473
3208
1.55
16.11
3.9
4.0
u/l
234.9
247.6
1.20
443
3024
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
544
3813
1.51
15.90
3.0
2.6
%
21.5
22.8
1.15
441
3231
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
36
77
4.72
15.87
1.1
1.1
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
24
35
6.90
15.69
1.1
1.0
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
469
3193
1.55
15.68
2.0
1.7
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
1552
13081
1.35
15.66
5.9
5.0
estimate
0.0
0.0
0.50
349
2473
(3021960) Folate [Moles/volume] in Serum or Plasma
852
6547
1.41
15.25
1.6
1.6
nmol/l
20.4
20.3
0.05
741
5593
(3029937) Albumin [Presence] in Urine by Test strip
913
7121
1.39
14.91
5.2
4.1
estimate
0.0
0.0
1.28
330
2364
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
431
2916
1.55
14.77
4.5
3.5
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
166
860
1.98
14.75
1.7
1.6
titre
230.0
244.7
—
6
34
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1935
16947
1.34
14.66
3.7
3.1
u/l
54.2
50.9
0.75
1794
15681
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
255
1520
1.73
14.50
3.3
3.2
pmol/l
4.3
4.4
1.37
232
1338
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
43
114
3.81
14.39
1.6
1.4
%
58.0
62.9
—
7
17
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1368
11425
1.34
14.20
3.2
2.8
ug/l
151.1
133.5
0.88
1252
10522
(3044889) 12 lead EKG panel
2113
18814
1.34
13.93
4.6
3.9
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
269
1647
1.69
13.87
2.4
2.4
au/ml
13.3
22.2
—
7
82
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1061
8562
1.35
13.76
3.5
3.2
u/l
33.0
37.5
0.67
991
8141
(3023520) Reticulocytes [#/volume] in Blood
373
2482
1.57
13.73
2.5
2.5
e9/l
67.3
68.8
0.36
288
1901
(40761511) CBC panel - Blood by Automated count
2923
27497
1.52
13.63
20.5
14.2
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
801
6208
1.38
13.35
4.6
3.6
—
—
—
0
0
(21494815) CD4 cells/100 lymphocytes in Specimen
57
192
3.00
13.16
1.6
2.2
%
47.1
45.0
0.19
12
21
(3002032) Base excess in Venous blood by calculation
388
2629
1.54
13.15
4.6
3.7
mmol/l
1.6
2.0
1.91
307
2098
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
348
2302
1.57
13.12
4.5
3.9
mmol/l
1.2
1.2
1.06
310
1996
(3015377) Calcium [Moles/volume] in Serum or Plasma
1127
9242
1.33
12.93
3.5
3.4
mmol/l
2.3
2.4
2.41
978
8039
(3043409) Potassium [Moles/volume] in Arterial blood
158
844
1.92
12.87
4.6
4.0
mmol/l
3.8
3.9
0.66
150
784
(3027945) Reticulocytes/100 erythrocytes in Blood
468
3321
1.48
12.68
2.6
2.5
%
1.8
1.8
0.15
415
2936
(3021447) Carbon dioxide [Partial pressure] in Venous blood
387
2644
1.52
12.61
4.6
3.7
kpa
5.9
5.8
0.05
374
2561
(3021589) Normoblasts [#/volume] in Blood
1389
11776
1.31
12.42
12.8
9.7
e9/l
0.0
0.0
0.11
1167
9608
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
188
1075
1.79
12.35
1.7
1.8
u/l
36.3
38.5
0.89
168
934
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
52
174
3.02
12.17
1.9
2.2
%
12.0
14.1
0.67
26
75
(4268621)
66
252
2.65
12.12
2.4
2.3
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
365
2491
1.52
11.93
3.6
2.9
ng/l
272.3
215.2
1.33
329
2275
(3020630) Protein [Mass/volume] in Serum or Plasma
352
2384
1.53
11.92
2.3
2.5
g/l
65.7
66.3
0.78
315
2170
(3020891) Body temperature
194
1132
1.76
11.90
4.9
4.5
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
61
226
2.73
11.88
2.0
2.4
e9/l
1.2
1.1
0.45
36
140
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
40
116
3.48
11.80
1.5
2.3
u/ml
2063.0
1276.7
0.23
40
116
(3014111) Lactate [Moles/volume] in Serum or Plasma
358
2447
1.52
11.61
7.5
6.9
mmol/l
1.4
1.4
0.05
345
2352
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
830
6592
1.35
11.59
2.7
2.4
—
—
—
0
0
(3009343) pH of Capillary blood
273
1760
1.60
11.47
4.5
3.8
ph
7.4
7.4
0.29
47
224
(3000991) Gas panel - Venous blood
344
2338
1.53
11.45
9.5
8.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
16
21
7.65
11.42
1.1
1.0
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
301
1988
1.57
11.40
2.3
2.3
—
—
—
0
0
(3012501) Base excess in Blood by calculation
125
648
1.97
11.15
5.1
4.6
mmol/l
2.4
2.7
0.73
85
445
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
45
146
3.11
11.13
2.2
2.5
e9/l
0.2
0.2
0.55
36
129
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
274
1784
1.58
11.04
4.6
3.8
kpa
5.1
5.2
0.47
252
1651
(3014148) Varicella zoster virus Ab [Titer] in Serum
66
266
2.51
10.90
1.2
1.1
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
609
4652
1.38
10.83
3.5
2.8
e6/l
1.0
1.1
0.26
368
2655
(3017446) Testosterone [Moles/volume] in Serum or Plasma
283
1868
1.56
10.75
3.4
2.2
nmol/l
12.3
12.4
0.04
253
1628
(3023183) Ammonium ion [Moles/volume] in Plasma
115
587
1.99
10.74
2.8
2.8
umol/l
32.5
37.1
1.02
102
482
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
261
1698
1.58
10.55
4.6
3.8
mmol/l
1.6
1.9
0.49
183
1238
(40767503) Oxygen content in Capillary blood by calculation
119
619
1.96
10.53
2.9
2.5
%
16.9
15.9
1.61
61
322
(3042936) Bacteria identified in Isolate by Culture
520
3892
1.40
10.42
2.2
2.1
—
—
—
0
0
(3010421) pH of Blood
139
764
1.86
10.42
4.9
4.3
ph
7.4
7.4
0.10
122
639
(3015171) Extractable nuclear Ab [Units/volume] in Serum
159
911
1.78
10.41
1.3
1.2
u/ml
0.3
1.0
1.28
11
80
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
71
303
2.37
10.38
1.2
1.1
—
—
—
0
0
(1616796) Gas panel - Central venous blood
122
649
1.91
10.12
4.3
3.8
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
258
1693
1.57
10.06
1.7
1.7
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1191
10094
1.28
10.04
4.9
3.9
—
—
—
0
0
(40758558) Short blood count panel - Blood
834
6754
1.31
9.94
7.5
6.6
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
257
1690
1.56
9.93
1.6
1.5
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
123
666
1.88
9.69
1.6
1.9
mg/l
10.9
11.6
0.32
112
611
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
105
539
1.98
9.68
3.9
3.5
%
56.6
57.8
0.48
105
539
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
210
1329
1.62
9.54
1.6
1.7
g/l
1.6
1.5
0.18
184
1149
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
44
155
2.86
9.48
2.2
2.4
e6/l
476.6
536.7
0.31
35
130
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
191
1188
1.64
9.30
2.4
1.9
ug/l
2.3
2.7
0.15
155
1042
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
84
404
2.11
9.26
3.4
3.0
u/ml
69.0
1941.1
—
6
31
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
81
385
2.13
9.21
5.4
6.6
mg/l
11.1
12.0
1.04
71
357
(3030905) Polymorphonuclear cells [#/volume] in Blood
101
521
1.97
9.20
3.8
3.3
e9/l
3.7
4.2
1.94
101
521
(3028026) IgM [Mass/volume] in Serum or Plasma
236
1549
1.56
9.20
2.2
1.8
g/l
1.3
1.4
0.14
218
1406
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
101
522
1.96
9.15
6.5
5.6
iu/ml
398.7
3916.3
0.56
17
69
(3019150) Specific gravity of Urine by Refractometry
722
5792
1.31
9.10
5.1
4.1
kg/l
1.0
1.0
0.12
93
872
(40761536) Microorganisms panel - Urine sediment
324
2285
1.46
8.97
5.0
4.1
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
139
802
1.77
8.93
2.0
1.7
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
46
172
2.70
8.89
1.8
2.2
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
453
3402
1.38
8.82
10.1
7.4
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
310
2175
1.47
8.82
3.9
3.1
kpa
4.5
4.6
0.29
301
2097
(3006245) CD3-CD19+ cells/100 cells in Blood
29
83
3.52
8.79
2.1
2.2
%
12.6
9.3
0.65
24
76
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
747
6048
1.30
8.76
1.8
1.7
pmol/l
11784958.8
24437789.2
0.46
594
5021
(3037522) Nuclear Ab [Titer] in Serum
442
3314
1.38
8.69
1.5
1.3
titre
602.9
510.1
0.52
83
700
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
28
79
3.57
8.67
1.1
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
295
2057
1.48
8.66
3.8
3.8
%
1.1
0.6
0.73
75
463
(44806071)
15
25
6.02
8.65
1.1
1.0
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
183
1154
1.62
8.46
2.0
1.9
—
—
—
0
0
(3023323) Follitropin [Units/volume] in Serum or Plasma
160
977
1.67
8.40
1.7
1.4
iu/l
26.5
28.9
0.36
126
828
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
169
1052
1.64
8.24
2.0
1.8
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
117
659
1.80
8.18
1.6
1.6
—
—
—
0
0
(40761535) Cells panel - Urine sediment
321
2303
1.44
8.12
4.2
3.4
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
18
38
4.76
8.11
1.1
1.2
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
18
38
4.76
8.11
1.9
2.3
umol/l
20.5
18.1
0.28
18
38
(3013512) EKG study
943
7932
1.26
8.07
4.4
4.0
—
—
—
0
0
(3000060) B lymphocytes [#/volume] in Blood
22
55
4.02
8.06
2.2
2.2
e6/l
157.0
147.7
—
10
26
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
79
394
2.03
7.96
1.6
1.6
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
129
754
1.74
7.96
2.2
1.8
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
150
918
1.66
7.82
2.8
3.3
mg/l
26.7
69.2
2.09
121
747
(3004119) Hemoglobin [Mass/volume] in Venous blood
250
1722
1.49
7.81
4.0
3.2
g/l
127.9
128.0
0.02
240
1676
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
146
889
1.67
7.77
2.8
3.2
ratio
1.3
1.7
—
8
71
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2590
24396
1.28
7.75
6.6
5.9
mmol/mol
40.0
40.1
0.19
2394
22466
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
66
312
2.14
7.67
1.6
1.6
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
149
917
1.65
7.61
2.8
3.2
mg/l
34.3
117.7
0.75
119
743
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
403
3045
1.37
7.53
2.8
2.8
umol/l
7.7
8.9
0.54
339
2664
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
90
481
1.90
7.46
1.5
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
117
679
1.75
7.43
1.6
1.6
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
2932
28124
1.36
7.41
13.3
10.4
u/l
25.9
25.7
0.17
2814
27053
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
631
5099
1.29
7.38
2.9
3.0
mmol/l
2.4
2.5
0.90
555
4458
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
25
74
3.40
7.24
1.6
1.2
%
30.6
21.7
—
8
11
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
163
1041
1.59
7.19
2.3
2.3
g/l
9.6
10.3
1.36
128
884
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
59
274
2.17
7.19
2.4
2.8
—
—
—
0
0
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
549
4374
1.31
7.13
3.7
3.0
e6/l
2.6
2.2
0.48
304
2394
(4035726)
325
2397
1.39
7.03
1.4
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
166
1075
1.57
6.92
5.6
4.1
mmol/l
24.7
24.8
0.24
148
996
(3005322) IgE [Units/volume] in Serum or Plasma
220
1516
1.48
6.88
1.3
1.3
u/ml
332.3
193.1
0.56
205
1395
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
16
36
4.46
6.70
1.1
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
14
28
5.02
6.70
1.1
1.2
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
402
3092
1.34
6.68
1.7
1.4
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
310
2290
1.39
6.65
4.0
4.0
%
1.0
0.9
0.12
92
665
(3024980) IgG subclass 4 [Mass/volume] in Serum
73
381
1.94
6.54
1.7
1.6
g/l
0.7
0.8
0.93
55
290
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
16
37
4.34
6.49
1.1
1.2
—
—
—
0
0
(3027273) Bicarbonate [Moles/volume] in Venous blood
201
1382
1.48
6.37
4.3
3.3
mmol/l
25.1
25.3
0.44
191
1339
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
82
449
1.85
6.36
2.3
1.9
pmol/l
180.8
201.5
0.77
76
421
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
100
582
1.74
6.34
1.4
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
100
582
1.74
6.34
1.5
1.3
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
284
2085
1.40
6.32
4.5
4.0
ng/l
109.5
91.5
1.50
244
1789
(3011985) Renin [Units/volume] in Plasma
64
326
1.98
6.17
1.5
1.4
mu/l
89.9
46.1
0.49
59
288
(3002385) Erythrocyte distribution width [Ratio]
2329
21877
1.22
6.06
25.4
18.0
%
13.8
13.8
1.25
2285
21359
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
79
435
1.84
6.04
1.2
1.3
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
166
1110
1.52
6.03
2.2
2.2
g/l
3.8
3.9
0.08
114
802
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
166
1111
1.52
6.01
2.3
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
166
1112
1.52
5.99
2.3
2.2
g/l
7.5
7.4
0.30
117
840
(3025159) Blasts/100 leukocytes in Blood
275
2030
1.39
5.93
3.9
4.1
%
0.0
0.4
1.21
78
502
(40760888) Immunoglobulin light chains.free panel - Serum
113
694
1.65
5.90
2.9
3.4
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
86
490
1.78
5.89
1.6
1.6
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
193
1343
1.46
5.79
4.8
4.1
mmol/l
23.6
24.2
1.88
176
1203
(4198724)
23
75
3.08
5.76
1.3
1.9
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
290
2172
1.37
5.73
4.0
4.0
%
0.1
0.1
0.24
87
611
(44790048)
62
321
1.95
5.73
1.5
1.5
—
—
—
0
0
(44806118)
62
321
1.95
5.73
1.5
1.5
—
—
—
0
0
(44790049)
62
321
1.95
5.73
1.5
1.5
—
—
—
0
0
(44790047)
62
321
1.95
5.73
1.5
1.5
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
31
120
2.60
5.71
1.1
1.2
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
24
81
2.98
5.68
1.2
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
24
81
2.98
5.68
1.1
1.1
—
—
—
0
0
(3009224) EGFR gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
9
7
12.89
5.58
1.1
1.0
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
20
61
3.29
5.58
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
37
158
2.36
5.56
1.1
1.2
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
114
713
1.62
5.56
5.6
3.7
mg/l
1.7
1.6
0.49
106
641
(3028626) Oxygen [Partial pressure] in Capillary blood
111
690
1.63
5.55
4.6
3.4
kpa
8.6
8.1
2.41
104
638
(3014271) Vancomycin [Susceptibility]
35
146
2.41
5.54
2.7
3.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
11
21
5.25
5.52
2.0
2.2
—
—
—
0
0
(3004451) EKG impression Narrative
34
141
2.43
5.45
1.5
1.3
—
—
—
0
0
(3022313) Gas panel - Capillary blood
181
1261
1.46
5.41
5.4
4.0
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
57
293
1.96
5.40
1.4
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
118
751
1.59
5.37
2.8
3.3
mmol/l
24.5
24.9
0.54
107
660
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
32
130
2.48
5.36
1.2
1.1
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
16
43
3.73
5.36
1.5
1.4
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
58
301
1.94
5.35
3.9
4.0
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
102
628
1.64
5.31
1.4
1.2
u/ml
15.1
3.5
1.12
17
57
(40760892) CBC W Ordered Manual Differential panel - Blood
679
5742
1.23
5.23
5.3
4.4
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
581
4832
1.25
5.23
1.6
1.5
g/l
2.3
2.5
2.11
348
2948
(3023511) Choriogonadotropin [Units/volume] in Urine
63
341
1.86
5.14
1.3
1.3
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
24
86
2.80
5.14
1.2
1.2
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
975
8555
1.20
5.13
3.4
3.2
mmol/l
7.0
7.5
2.32
824
7173
(3048689) Calprotectin [Mass/mass] in Stool
374
2957
1.30
5.10
2.1
2.3
ug/g
141.7
139.9
0.03
294
2335
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
13
31
4.21
5.09
1.4
2.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
2596
24785
1.22
5.08
19.7
14.0
ml/min/173m2
78.8
78.7
0.09
2231
20437
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
102
636
1.62
5.07
1.5
1.2
u/ml
8.2
7.5
0.06
18
105
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
125
819
1.55
5.04
1.3
1.3
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
22
76
2.91
5.03
1.2
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
152
1040
1.48
5.00
2.2
2.3
g/l
3.1
3.1
0.00
115
823
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
39
180
2.18
4.93
1.1
1.1
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
39
180
2.18
4.93
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
39
180
2.18
4.93
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
107
680
1.59
4.93
1.4
1.2
u/ml
62.8
46.0
—
5
38
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
27
106
2.56
4.87
1.4
1.7
nmol/l
1.8
9.4
1.08
22
90
(3034426) Prothrombin time (PT)
23
83
2.78
4.87
1.3
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
449
3657
1.26
4.83
1.2
1.2
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
334
2622
1.30
4.81
1.9
2.2
g/l
0.2
0.2
0.16
307
2445
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
39
182
2.16
4.81
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
39
182
2.16
4.81
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
39
182
2.16
4.81
1.1
1.1
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
93
576
1.63
4.77
3.5
3.1
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
25
96
2.62
4.72
1.1
1.3
g/l
—
0.2
—
0
10
(3006184) Hemoglobin [Mass/volume] in Capillary blood
102
648
1.59
4.72
2.3
2.2
g/l
132.6
127.3
1.19
80
475
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
45
224
2.02
4.70
1.2
1.1
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
14
38
3.70
4.64
1.3
2.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
66
375
1.78
4.64
1.5
1.4
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
117
771
1.54
4.63
1.8
1.7
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
57
310
1.85
4.62
1.4
1.3
pmol/l
320.4
265.6
0.54
51
241
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
316
2477
1.30
4.61
2.9
2.4
u/l
31.0
38.3
2.17
274
2111
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
11
25
4.41
4.56
3.5
2.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
9
11
8.20
4.56
1.2
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
797
6931
1.20
4.55
1.7
1.6
mmol/l
1.4
1.4
0.16
683
5793
(40768446) Kidney Pathology biopsy report
25
98
2.56
4.54
1.8
1.6
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
3015
29339
1.30
4.50
31.2
21.9
e9/l
246.2
247.8
0.66
2951
28525
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
45
228
1.99
4.50
1.7
1.5
—
—
—
0
0
(3010503) CD19 cells [#/volume] in Blood
33
148
2.24
4.50
2.1
2.4
e9/l
0.1
0.1
0.12
33
141
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
29
124
2.35
4.41
2.3
2.5
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
921
8134
1.18
4.39
3.5
3.3
mg/l
658.1
341.3
0.91
608
5214
(3024731) MCV [Entitic volume]
3015
29353
1.29
4.38
31.1
21.8
fl
91.5
91.2
2.45
2965
28878
(3019225) pH of Specimen
342
2728
1.28
4.37
5.3
4.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
3015
29355
1.29
4.36
31.1
21.8
pg
30.4
30.3
0.88
2965
28878
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
21
77
2.74
4.34
1.1
1.3
%
87.8
84.0
0.15
13
44
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
21
77
2.74
4.34
1.1
1.1
%
89.3
89.0
0.02
12
43
(3026361) Erythrocytes [#/volume] in Blood
3015
29357
1.29
4.34
31.2
21.9
e12/l
4.4
4.5
7.53
2937
28456
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
116
775
1.51
4.33
1.2
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
31
138
2.26
4.31
1.2
1.3
nmol/l
139.0
136.5
0.13
31
138
(3010813) Leukocytes [#/volume] in Blood
3015
29363
1.29
4.29
31.3
21.9
e9/l
7.0
6.8
2.68
2934
28455
(3020682) Albumin/Creatinine [Ratio] in Urine
966
8580
1.18
4.28
4.4
4.0
mg/mmol
12.3
9.0
0.98
617
5472
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
72
430
1.69
4.28
1.5
1.4
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
3015
29365
1.29
4.27
31.4
22.0
g/l
132.9
134.4
6.90
2966
28898
(3027456) Digoxin [Moles/volume] in Serum or Plasma
97
626
1.57
4.24
3.6
3.1
nmol/l
0.9
0.8
0.38
73
478
(3016038) Potassium [Moles/volume] in Urine
36
172
2.10
4.22
1.8
1.2
mmol/l
35.4
35.6
0.02
31
151
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
78
478
1.65
4.21
1.4
1.3
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
24
96
2.51
4.21
1.8
2.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2583
24773
1.19
4.20
4.4
3.9
mmol/l
1.3
1.3
2.18
2366
22483
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
175
1273
1.40
4.20
2.8
2.6
%
0.7
0.7
0.65
168
1215
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
136
945
1.46
4.19
2.7
2.7
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
116
781
1.50
4.19
1.2
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2666
25648
1.20
4.16
5.1
4.6
mmol/l
6.0
6.0
0.21
2423
23257
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
12
32
3.76
4.08
1.5
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
79
490
1.63
4.08
1.4
1.2
u/ml
63.3
46.2
—
9
53
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
55
309
1.79
4.06
2.0
1.5
nmol/l
0.3
0.3
0.73
41
242
(42529406) Shigella sp [Presence] in Stool by Culture
116
788
1.49
4.02
1.2
1.2
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
38
190
2.01
3.97
1.9
1.4
promille
1.1
1.1
0.01
31
150
(3052851) Hemolysis interference index of Serum or Plasma
119
815
1.48
3.97
3.4
3.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
64
379
1.70
3.95
1.5
1.5
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
115
785
1.48
3.90
2.0
2.1
g/l
0.0
0.0
0.00
105
720
(3017704) Immunofixation for Urine
35
171
2.06
3.90
1.1
1.6
—
—
—
0
0
(3016228) CD19 cells/100 cells in Blood
24
101
2.39
3.81
1.8
2.2
%
8.3
7.7
0.15
24
96
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
29
3.80
3.80
1.0
1.1
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
271
2139
1.29
3.79
3.1
2.7
ml/min/173m2
61.9
63.7
0.32
121
869
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
125
876
1.44
3.73
2.0
2.0
g/l
36.8
37.5
0.77
105
755
(3021901) Oxygen saturation in Capillary blood
86
559
1.55
3.69
2.6
2.9
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
31
148
2.10
3.68
2.1
2.8
%
45.0
38.9
0.77
13
55
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
12
6.68
3.67
4.8
5.8
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
18
67
2.70
3.65
1.0
1.1
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
112
772
1.47
3.65
1.3
1.4
ug/g
281.8
276.7
0.10
62
452
(3027135) IgG subclass 1 [Mass/volume] in Serum
43
232
1.86
3.64
1.5
1.3
g/l
6.3
7.0
0.82
31
162
(3024139) IgG subclass 3 [Mass/volume] in Serum
43
232
1.86
3.64
1.5
1.3
g/l
0.4
0.4
0.61
31
162
(3028192) IgG subclass 2 [Mass/volume] in Serum
43
232
1.86
3.64
1.5
1.3
g/l
2.9
2.9
0.06
31
162
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
19
73
2.61
3.63
1.2
1.1
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
2493
23928
1.17
3.63
22.8
16.0
%
38.8
39.4
2.01
1581
16554
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
192
1454
1.34
3.62
2.3
2.4
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
1678
15676
1.14
3.56
2.9
2.8
—
—
—
0
0
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
112
776
1.46
3.56
2.1
2.1
g/l
0.0
0.0
0.00
104
719
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
19
74
2.58
3.54
1.2
1.0
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
2678
25866
1.18
3.54
5.0
4.4
mmol/l
4.4
4.6
25.02
2472
23817
(3023419) Bacteria identified in Sputum by Culture
60
361
1.67
3.53
3.2
2.4
—
—
—
0
0
(4062490)
43
235
1.84
3.51
1.5
1.3
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
71
448
1.60
3.47
1.4
1.3
u/ml
302.7
273.2
0.39
46
274
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
36
3.34
3.47
1.2
1.0
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
12
36
3.34
3.47
6.6
6.0
—
—
—
0
0
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
132
948
1.41
3.46
2.3
2.2
g/l
0.8
1.1
0.66
111
822
(40768804) Tissue Pathology biopsy report
1181
10791
1.15
3.45
2.2
2.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
91
611
1.50
3.39
1.4
1.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
32
160
2.01
3.39
1.3
1.3
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
110
769
1.45
3.36
1.6
1.6
iu/ml
0.1
8.3
0.58
25
164
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
25
114
2.20
3.34
1.1
1.1
nmol/l
0.1
4.6
—
5
23
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
32
161
2.00
3.34
1.3
1.3
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
117
830
1.42
3.30
2.0
2.1
g/l
0.0
0.0
0.21
106
762
(3037756) Immunofixation for Serum or Plasma
92
625
1.49
3.26
1.5
1.6
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
53
316
1.69
3.25
1.6
1.6
%
60.0
61.8
0.13
30
200
(3042733) HLA Ab [Presence] in Serum
18
72
2.51
3.20
5.7
4.8
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
245
1954
1.27
3.19
1.2
1.2
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
7
11
6.37
3.18
1.0
1.0
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
47
273
1.73
3.17
1.5
1.6
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
70
451
1.56
3.17
1.2
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
25
117
2.15
3.16
1.2
1.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
154
2030
0.75
3.14
1.3
1.4
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
13
44
2.96
3.13
6.2
9.0
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
17
67
2.55
3.12
6.6
8.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
2727
26447
1.17
3.11
5.6
4.9
mmol/l
2.5
2.7
23.79
2509
24206
(3041096) Erythrocytes [Presence] in Urine by Automated
787
7033
1.16
3.10
4.1
3.4
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
32
166
1.94
3.09
2.0
2.3
e6/l
809.4
683.3
0.54
16
66
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
12
39
3.08
3.09
1.3
1.1
—
—
—
0
0
(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma
12
39
3.08
3.09
1.0
1.4
nmol/l
4.0
831255.8
—
5
32
(3017509) Phencyclidine [Presence] in Urine
8
16
5.01
3.05
1.8
1.1
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
625
5498
1.17
3.02
1.3
1.3
u/ml
2.0
1.5
0.30
155
1445
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
152
1993
0.75
3.00
1.8
1.7
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
24
113
2.13
3.00
1.2
1.4
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
24
113
2.13
3.00
1.2
1.4
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
22
100
2.21
2.99
1.0
1.1
miu/ml
1473.4
1667.3
0.30
22
100
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2651
25679
1.16
2.96
4.9
4.4
mmol/l
1.4
1.5
5.20
2438
23492
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
10
30
3.34
2.90
1.1
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
85
584
1.47
2.88
1.4
1.4
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
15
58
2.59
2.87
5.5
9.3
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
15
58
2.59
2.87
1.3
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
81
1164
0.69
2.83
1.8
1.7
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
81
554
1.47
2.82
1.6
1.7
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
30
159
1.89
2.75
3.5
3.5
—
—
—
0
0
(3003245) Complement C1 esterase inhibitor [Mass/volume] in Serum or Plasma
19
85
2.24
2.70
1.1
1.2
g/l
0.3
0.3
0.09
13
68
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
15
60
2.51
2.70
1.0
1.1
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
10
6.01
2.70
1.0
1.0
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
91
643
1.43
2.69
1.2
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
49
303
1.63
2.68
1.5
2.0
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
50
311
1.62
2.67
1.3
1.3
—
—
—
0
0
(3019977) pH of Arterial blood
29
154
1.89
2.65
2.4
2.9
ph
7.4
7.4
—
8
52
(3024869) Neuronal Ab [Presence] in Serum
12
43
2.80
2.64
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
29
155
1.88
2.61
1.7
1.5
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
29
155
1.88
2.61
1.7
1.5
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
97
698
1.40
2.60
1.4
1.2
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
488
4261
1.17
2.59
1.3
1.3
iu/ml
46.7
35.9
0.39
140
1335
(3028707) Methadone [Presence] in Urine by Screen method
49
306
1.61
2.58
1.5
2.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
796
8765
0.88
2.58
3.2
2.9
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
318
2679
1.21
2.55
1.7
1.5
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
182
1443
1.28
2.54
1.2
1.2
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
146
1125
1.31
2.53
2.4
2.7
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
48
300
1.61
2.53
1.2
1.3
nmol/l
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
62
413
1.51
2.49
1.2
1.1
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
51
325
1.58
2.49
4.6
6.3
mmol/l
6.7
7.4
0.88
43
276
(3026493) Urate [Moles/volume] in Serum or Plasma
784
7103
1.14
2.49
3.1
2.7
umol/l
2778.9
5528.5
1.59
648
6122
(4024509)
42
255
1.66
2.48
1.6
1.6
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
16
69
2.33
2.48
2.5
2.7
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
16
69
2.33
2.48
1.1
1.1
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
7
16
4.38
2.47
1.6
1.3
%
43.6
43.6
—
7
9
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
18
82
2.20
2.47
1.6
2.2
—
—
—
0
0
(3037121) Protein [Mass/volume] in Urine
129
982
1.33
2.45
3.1
3.0
g/l
0.4
0.3
0.42
59
400
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
69
475
1.46
2.38
4.1
3.2
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
90
651
1.39
2.37
1.2
1.2
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
25
132
1.90
2.35
2.8
2.3
mmol/l
8.8
9.5
0.49
18
103
(3008898) HLA-B27 [Presence]
104
772
1.36
2.34
1.1
1.1
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
99
1325
0.74
2.31
1.5
1.5
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
29
162
1.80
2.31
1.2
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
21
105
2.01
2.30
2.6
1.8
umol/l
184.5
106.3
0.40
12
62
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
18
85
2.12
2.28
3.1
2.7
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
18
85
2.12
2.28
3.1
2.7
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
16
72
2.23
2.27
1.0
1.3
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
29
163
1.79
2.26
1.2
1.2
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
7
18
3.89
2.25
1.0
1.1
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
51
334
1.54
2.24
1.4
1.4
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
90
659
1.38
2.22
1.4
1.3
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
5
9
5.56
2.21
1.0
1.0
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
31
180
1.73
2.18
1.7
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
8
24
3.34
2.18
1.1
1.1
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
16
74
2.17
2.14
1.1
1.1
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
50
330
1.52
2.14
1.4
1.4
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
28
159
1.77
2.13
1.3
2.2
umol/l
14.1
25.6
—
5
12
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
69
489
1.42
2.08
1.7
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
49
325
1.52
2.06
1.4
1.4
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
18
341
0.53
2.04
1.4
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
49
326
1.51
2.03
1.4
1.4
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
96
722
1.34
2.03
1.4
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
49
327
1.51
2.01
1.4
1.4
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
69
493
1.41
2.00
1.8
1.5
—
—
—
0
0
(3052318) Alpha-1-Microglobulin [Mass/volume] in Urine
9
32
2.82
2.00
2.1
2.7
—
12.2
—
0
5
(3005033) Fetal Nuchal fold Thickness US
18
338
0.53
1.99
1.4
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
49
328
1.50
1.98
1.4
1.4
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
19
349
0.54
1.96
1.5
1.5
—
—
—
0
0
(4010399)
225
1886
1.21
1.96
1.4
1.4
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
20
105
1.91
1.95
1.1
1.3
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
56
387
1.45
1.95
4.4
2.6
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
33
203
1.63
1.92
1.3
1.1
u/ml
47.8
66.1
—
6
13
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
39
251
1.56
1.89
1.2
1.2
—
—
—
0
0
(3008536) Aspergillus sp Ab [Presence] in Serum
12
52
2.31
1.87
2.7
1.9
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
17
86
1.98
1.84
1.1
1.6
—
—
—
0
0
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
13
59
2.21
1.84
1.9
1.5
ug/l
0.6
0.4
—
7
34
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
68
493
1.39
1.84
1.7
1.4
—
19.1
—
0
13
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
23
3.05
1.80
1.3
1.0
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
25
412
0.60
1.76
1.4
1.4
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
770
7103
1.11
1.76
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
25
411
0.61
1.75
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
25
410
0.61
1.73
1.4
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
40
265
1.52
1.73
2.4
2.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
25
409
0.61
1.72
1.4
1.4
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
32
202
1.59
1.71
1.3
1.2
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
441
3947
1.14
1.70
1.8
1.8
—
—
—
0
0
(3036603) Volume of Urine
28
171
1.64
1.70
1.5
1.4
ml
1752.3
1923.5
—
6
39
(3029075) Extractable nuclear Ab panel - Serum
14
68
2.06
1.70
1.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
28
444
0.63
1.69
1.4
1.5
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
78
587
1.34
1.69
1.9
1.8
iu/l
6.6
5.1
0.34
23
193
(3004616) Nuclear Ab [Presence] in Serum
45
308
1.47
1.68
1.3
1.2
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
61
442
1.39
1.68
1.7
1.5
u/ml
121.1
118.2
—
10
87
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
90
695
1.30
1.64
1.4
1.3
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
15
76
1.98
1.64
1.1
1.5
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
5
14
3.58
1.61
1.6
1.3
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
213
1816
1.18
1.59
1.5
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
72
543
1.33
1.56
1.3
1.9
—
—
—
0
0
(4133840)
12
57
2.11
1.55
1.3
1.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
36
241
1.50
1.52
1.5
1.4
%
28.9
29.3
0.03
22
149
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
39
266
1.47
1.51
1.1
1.1
u/l
53.5
59.9
0.40
29
180
(3051611) Lipemic interference index of Serum or Plasma
41
283
1.45
1.49
3.6
3.3
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
30
194
1.55
1.48
1.5
1.8
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
448
4052
1.12
1.48
1.2
1.2
u/ml
8.0
12.9
0.96
139
1552
(3017569) Oxygen content in Arterial blood
22
132
1.67
1.45
1.5
2.6
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
38
260
1.47
1.45
1.1
1.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
40
277
1.45
1.44
2.7
3.3
%
59.3
56.8
0.24
29
169
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
52
2.12
1.44
1.1
1.1
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
7
29
2.42
1.39
3.9
2.8
u/field
0.4
0.6
—
7
29
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
19
111
1.72
1.39
1.0
1.1
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
48
347
1.39
1.38
2.6
2.4
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
508
5543
0.90
1.38
3.0
3.1
ug/l
0.8
0.8
0.06
354
3804
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
13
67
1.94
1.38
1.3
1.3
—
—
—
0
0
(3013005) Retinol [Moles/volume] in Serum or Plasma
16
89
1.80
1.37
1.7
1.7
umol/l
2.1
2.0
0.17
16
81
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
59
778
0.75
1.36
1.5
1.5
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
58
434
1.34
1.36
1.6
1.7
—
—
—
0
0
(3017315) Amylase [Enzymatic activity/volume] in Urine
22
135
1.63
1.35
1.1
1.2
u/l
205.0
393.7
0.86
22
122
(40761995) Spermatozoa Progressive [#/volume] in Semen
0
37
0.00
1.34
0.0
3.1
—
—
—
0
0
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
0
37
0.00
1.34
0.0
6.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
102
825
1.24
1.34
2.2
1.8
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
175
2043
0.85
1.33
1.3
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
198
1708
1.17
1.32
1.4
1.4
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
43
308
1.40
1.32
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
63
480
1.32
1.32
1.5
1.6
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
188
1616
1.17
1.32
1.2
1.2
iu/ml
144.6
152.4
0.09
79
582
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
26
168
1.55
1.31
1.6
1.5
u/l
7.9
7.5
0.06
16
77
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
6
24
2.50
1.30
1.0
1.0
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
18
2.78
1.28
1.6
1.4
umol/24h
379.4
391.9
—
5
18
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
11
55
2.00
1.27
1.1
1.2
—
—
—
0
0
(3033923) Metanephrine [Moles/time] in 24 hour Urine
11
55
2.00
1.27
1.1
1.1
umol/24h
0.6
0.7
—
5
33
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
6
135
0.44
1.27
17.2
12.7
nmol/l
626.3
827.8
—
6
130
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
29
194
1.50
1.26
1.1
1.3
mmol/l
9.8
12.6
—
8
53
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
87
697
1.25
1.25
1.6
1.5
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
149
1262
1.19
1.25
1.4
1.3
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
317
2841
1.13
1.25
1.6
1.8
%
1.6
1.5
1.24
274
2493
(3011648) Oxygen content in Venous blood
31
212
1.47
1.22
3.5
2.6
%
10.4
11.2
0.44
31
212
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
364
3295
1.12
1.21
4.9
4.5
%
33.1
32.6
0.37
292
2164
(40761539) Cells [T